course contents per week course contents lectures week ... · spectroscopy, fluorimetry 6...
TRANSCRIPT
Introduction to Pharmacology (EF1254)
ECTS: 4 4 h/w theory Period: Feb - June
Coordinator: Atilla Akdemir, PhD
Course objective: Providing a basic understanding of pharmacology and its terminology and giving a short introduction to its disciplines. Also, we will discuss several proteins that are important players in pharmacology, such as enzymes and receptors. Course contents: Introduction to pharmacology, research disciplines in pharmacology, pharmacokinetics,
pharmacodynamics, cells, enzymes, receptors (classes, functions, structure), ligands (agonists, inverse agonists, neutral antagonists, allosteric modulators), intracellular signalling pathways. Learning outcomes: The students:
will be able to discuss how drugs act within the body and how they can treat diseases will be able to discuss the most important receptor classes and their signaling cascades
will be able to describe several functional classes of ligands
will be able to describe pharmacokinetics and its importance for medicine Form of tuition: Lectures, tutorials and self-study
Course material: Powerpoint presentations, internet, text book Literature: Rang and Dale’s Pharmacology, International Edition, Seventh Edition, Elsevier Churchill Livingstone
Entry requirements: None
Course contents per week
Course contents – lectures Week Contents
1 General introduction to pharmacology and its disciplines
2 Introduction to proteins as targets for drugs
3 G-protein coupled receptors and intracellular signalling cascades
4 Kinase-linked receptors and intracellular signalling cascades
5 Ion channels
6 Nuclear receptors
7 Calcium as a second messenger
8 Drug absorption and distribution
9 Drug absorption and distribution
10 Drug metabolism and elimination
11 Drug metabolism and elimination
12 Pharmacokinetics
13 Pharmacokinetics
14 Pharmacogenetics, pharmacogenomics and "personalized medicine"
15 Drug discovery and development
Assessment and evaluation system
Mid-term study Number Contribution (%)
Mid-term exam 100
Quiz
Project
Reports
Seminar
Assignments
Presentation
Laboratory
Field work
Total 100
Contribution of mid-term studies to pass mark
40
Contribution of final exam to pass mark
60
Relationship between the learning outcomes of the course and the programme outcomes
No Programme outcomes 1 2 3 4 5
1 The graduates shall know the historical developments, the importance and characteristics of pharmacies in the world and Turkey. The graduates shall know the national and international healthcare related organizations.
x
2 The graduates shall know the ethical and legal principles in the field of pharmacy and pharmaceutical sciences.
x
3 The graduates will be able to communicate health-related subjects and drug-related information to patients, health professionals and other parties.
x
4 The graduates will be able to follow, understand and apply the latest developments in pharmacies and pharmaceutical sciences.
x
5 The graduates will have the administrative and technical proficiencies around the responsibility given by law.
x
6 The graduates will be able to organize pharmacies and other pharmaceutical applications according to the rules.
x
7 The graduates will understand and successfully take part in every stage from design of pharmaceutical products to their marketing.
x
8 The graduates will be able to plan and perform all issues within the pharmaceutical services in the hospital.
x
9 The graduates will have knowledge about the obtainment, production and product technologies and production, obtainment of the natural and chemical pharmaceutical raw materials.
x
10 The graduates will be able to inform patients, their relatives and (patient) organizations in issues according to the safety and quality of natural products.
x
11 The graduates will be able to recognize plants with medical, economic and toxic potential.
x
12 The graduates shall know and will be able to take part in quality assurance. x
13 The graduates shall know and successfully take part in the production and development of the biotechnological and radiopharmaceutical products.
x
14 The graduates will know the drug licensing policies, data protection, and evaluates the relationship between patent issues.
x
15 The graduates shall comprehend the issues of drug recognition, ensuring of drug quality, drug control and standardization.
x
16 The graduates shall know the therapeutic effects of the effective substances of drug and solves problems related to drug such as pharmacokinetic properties and stability
x
17 The graduates will be able to advice on intelligent and safe use of drugs, and they will assist in pharmacovigilance applications.
x
18
The graduates will know the major determinants of the extent and kinetics of drug and drug product instability (e.g., temperature, humidity, light, pH, oxygen, free radicals) and the common types of reactions (and their mechanisms) which influence drug and drug product stability (e.g., hydrolysis, oxidation, cyclization, racemization)
x
19 The graduates will be able to set-up and perform an (scientific) experiment, collect data, evaluate the results and to resolve the problems in the laboratory.
x
20 The graduates will be able to follow and acquire scientific and technological knowledge and improvements
x
21 The graduates will be able to control the physical, chemical, biological, toxicological and pharmaceutical characteristics of nanoformulations.
x
22 The graduates will have knowledge about the mechanism of actions of drugs, their side effects and the benefits of using controlled release and/or nanoformulations to increase the effects of drugs.
x
23 The graduates will become familiar with pharmaceutical data bases and knows how to use them to determine the state of the art of all pharmaceutical technologies.
x
contribution level: 1 (low) – 5 (high)
ECTS – workload table
Activity Number Time (hour) Total workload Class Hours 15 4 60
Other Applications
Final Examinations (including preparatory year) 1 2 2
Quiz
Term Paper/ Project
Portfolio Study
Reports
Learning Diary
Thesis/ Project
Seminar
Other
Working Hours out of Class 15 3 45
Assignments
Presentation
Mid-term Examinations (including time for preparation)
Project
Clinical Practice
Laboratory
Field Work
Total Workload 107
Total Workload / 25 4.28
ECTS Credit of Course 4
Second year courses
Analytical Chemistry II (EF2151)
ECTS: 6 3 h/w theory; 4 h/w practice Period: Sep - Jan
Coordinator: Evrim TEKKELİ, PhD
Course objective:
Providing current and detailed information about the instrumental techniques that are
especially used for drug, metabolite analysis. In this way the students will get the ability
to design and develop new analytical methods according to the type, properties of
analytes and their matrices.
Course contents:
Introduction to instrumental analytical methods, optical and spectroscopic techniques,
atomic spectroscopy (atomic absorption and fluorescence spectroscopy, atomic emission
spectroscopy, atomic mass spectroscopy), molecular spectroscopy (UV, VIS, molecular
luminescence spectroscopy, infrared spectroscopy, raman spectroscopy, nuclear
magnetic resonance spectroscopy, mass spectrometry), Electrochemistry and
electrochemical analysis, electrometric methods (coulometry, conductometry,
voltammetry, potentiometry), chromatographic methods (liquid chromatography, gas
chromatography, supercritical liquid chromatography and other modern chromatographic
techniques), electrophoresis, automated analytical techniques, the use of instrumental
analysis in the studies of bioequivalence and bioavailability and drug analyses.
Learning outcomes:
The students:
• will be able to understand techniques of an instrumental analysis
• will be able to analyze analytes in different matrices
• will be able to describe biological fluids, pharmacokinetics and monitorizing a
drug substance after administration
Form of tuition:
Lectures, tutorials and self-study
Course material:
Powerpoint presentations, videos
Literature:
Instrumental analysis, Skoog
Entry requirements:
None
Course contents per week
Course contents – lectures
Week Contents
1 Introduction to instrumental techniques
2 Optical and spectroscopic techniques
3 Atomic spectroscopy (atomic absorption and fluorescence spectroscopy, atomic emission spectroscopy, atomic mass spectroscopy)
4 Molecular spectroscopy (UV, VIS spectrometry)
5 Introduction to molecular luminescence spectroscopy, fluorimetry
6 Fluorimetry, phosphorimetry,chemiluminescence
7 Infrared spectroscopy, raman spectroscopy
8 Nuclear magnetic resonance spectroscopy, mass spectrometry
9 Introduction to electrochemical analysis and electrometric methods, culometry, conductometry
10 Voltammetry, potentiometry
11 General principles of chromatography
12 HPLC
13 GC
14 SFC and capillary electrophoresis
15
Micellary electrokinetic chromatography, application of instrumental analysis in bioequivalence, bioavailability studies, drug analyses
Course contents – practical courses
Week Contents
1 ____
2 ____
3 Some experiments to remind analytical chemistry 1
4 Spectrophotometric drug analysis
5 Spectrophotometric analysis
6 Spectrofluorimetric drug analysis
7 -------
8 HPLC study for drug analysis form pharmaceutical preparations
9 HPLC study for drug analysis from pharmaceutical preparations
10 HPLC study for drug analysis from biological fluids
11 HPLC study for drug analysis from biological fluids
12 UPLC study for drug analysis from pharmaceutical preparations
13 UPLC study for drug analysis from biological fluids
14 Literature survey for chromatographic analysis
15 Presentations about chromatographic drug analysis
Assessment and evaluation system
Mid-term study Number Contribution (%)
Mid-term exam 1 100
Quiz 2 10
Project --- ---
Reports --- ---
Seminar --- ---
Assignments ---
Presentation 1 5
Laboratory 13 ---
Field work --- ---
Total --- ---
Contribution of mid-term studies to pass mark
40
Contribution of final exam to pass mark
60
Relationship between the learning outcomes of the course and the programme outcomes
No Programme outcomes 1 2 3 4 5
1 The graduates shall know the historical developments, the importance and characteristics of pharmacies in the world and Turkey. The graduates shall know the national and international healthcare related organizations.
x
2 The graduates shall know the ethical and legal principles in the field of pharmacy and pharmaceutical sciences.
x
3 The graduates will be able to communicate health-related subjects and drug-related information to patients, health professionals and other parties.
x
4 The graduates will be able to follow, understand and apply the latest developments in pharmacies and pharmaceutical sciences.
x
5 The graduates will have the administrative and technical proficiencies around the responsibility given by law.
x
6 The graduates will be able to organize pharmacies and other pharmaceutical applications according to the rules.
x
7 The graduates will understand and successfully take part in every stage from design of pharmaceutical products to their marketing.
x
8 The graduates will be able to plan and perform all issues within the pharmaceutical services in the hospital.
x
9 The graduates will have knowledge about the obtainment, production and product technologies and production, obtainment of the natural and chemical pharmaceutical raw materials.
x
10 The graduates will be able to inform patients, their relatives and (patient) organizations in issues according to the safety and quality of natural products.
x
11 The graduates will be able to recognize plants with medical, economic and toxic potential.
x
12 The graduates shall know and will be able to take part in quality assurance. x
13 The graduates shall know and successfully take part in the production and development of the biotechnological and radiopharmaceutical products.
x
14 The graduates will know the drug licensing policies, data protection, and evaluates the relationship between patent issues.
x
15 The graduates shall comprehend the issues of drug recognition, ensuring of drug quality, drug control and standardization.
x
16 The graduates shall know the therapeutic effects of the effective substances of drug and solves problems related to drug such as pharmacokinetic properties and stability
x
17 The graduates will be able to advice on intelligent and safe use of drugs, and they will assist in pharmacovigilance applications.
x
18
The graduates will know the major determinants of the extent and kinetics of drug and drug product instability (e.g., temperature, humidity, light, pH, oxygen, free radicals) and the common types of reactions (and their mechanisms) which influence drug and drug product stability (e.g., hydrolysis, oxidation, cyclization, racemization)
x
19 The graduates will be able to set-up and perform an (scientific) experiment, collect data, evaluate the results and to resolve the problems in the laboratory.
x
20 The graduates will be able to follow and acquire scientific and technological knowledge and improvements
x
21 The graduates will be able to control the physical, chemical, biological, toxicological and pharmaceutical characteristics of nanoformulations.
x
22 The graduates will have knowledge about the mechanism of actions of drugs, their side effects and the benefits of using controlled release and/or nanoformulations to increase the effects of drugs.
x
23 The graduates will become familiar with pharmaceutical data bases and knows how to use them to determine the state of the art of all pharmaceutical technologies.
x
contribution level: 1 (low) – 5 (high)
ECTS – workload table
Activity Number Time (hour) Total workload Class Hours 15 3 45
Other Applications
Final Examinations (including preparatory year) 1 10 10
Quiz 2 2.5 5
Term Paper/ Project
Portfolio Study
Reports 2 3 6
Learning Diary
Thesis/ Project
Seminar
Other
Working Hours out of Class 4 5 20
Assignments
Presentation 1 5 5
Mid-term Examinations (including time for preparation)
1 6 6
Project 1 5 5
Clinical Practice
Laboratory 12 4 48
Field Work
Total Workload 150
Total Workload / 25 6
ECTS Credit of Course 6
Organic Chemistry (EF2156)
ECTS: 4 4 h/w theory Period: Sep - Jan
Coordinator: Binnur Temel, PhD
Course objective:
The course focuses on the properties and reactions of common classes of organic
compounds; the relationship between the structures of organic compounds and their
physical and chemical properties. Some reaction mechanisms are also covered.
Course contents:
Introduction to organic chemistry, orbitals and covalent bonds, structural isomers and
nomenclature. Chemical characteristics of alkanes, alkenes, alkynes, aromaticity and
benzene, alkyl halogens, alcohols, ethers, epoxides, thiols, aldehydes, ketones,
carboxylic acids and their derivatives, amines and amides, and their synthesis. Acidity
and basicity of organic compounds, and stereochemistry. Chemical reactions, basic
chemical reactions with mechanisms (substitutions, eliminations, free radical reactions,
etc.).
Learning outcomes:
Students will recognize the inherent properties of organic compounds, can systematically
name the structures, understand the mechanisms of reactions and gain the ability to
correlate this information with other disciplines.
Form of tuition:
Lectures, tutorials and self-study
Course material:
PowerPoint presentations, text book and internet
Literature:
Organic Chemistry, 3rd Edition by Janice Gorzynski Smith, McGraw-Hill
Organic Chemistry, 6th Edition by L. G. Wade, Jr., Pearson PrenticeHall
Entry requirements:
None
Course contents per week
Course contents – lectures
Week Contents
1 Structure and Bonding
2 Acids and Bases
3 Alkanes
4 Stereochemistry
5 Understanding Organic Reactions
6 Alkyl Halides
7 Alcohols, Ethers and Epoxides
8 Alkenes and Alkynes
9 Conjugation, Resonance and Dienes
10 Benzene and Aromatic Compounds
11 Carboxylic Acids and Their Derivatives
12 Amines
13 Carbohydrates
14 Amino Acids and Proteins
15 Lipids
Course contents – practical courses
Week Contents
1
2
3
4
Assessment and evaluation system
Mid-term study Number Contribution (%)
Mid-term exam 1 80
Quiz 2 5
Project - -
Reports - -
Seminar - -
Assignments - -
Presentation - -
Laboratory - -
Field work - -
Total 3 100
Contribution of mid-term
studies to pass mark
(%)
- 40
Contribution of final
exam to pass mark (%)
- 60
Total 100
Relationship between the learning outcomes of the course and the programme outcomes
No Programme outcomes 1 2 3 4 5
1 The graduates shall know the historical developments, the importance and characteristics of pharmacies in the world and Turkey. The graduates shall know the national and international healthcare related organizations.
2 The graduates shall know the ethical and legal principles in the field of pharmacy and pharmaceutical sciences.
3 The graduates will be able to communicate health-related subjects and drug-related information to patients, health professionals and other parties.
4 The graduates will be able to follow, understand and apply the latest developments in pharmacies and pharmaceutical sciences.
5 The graduates will have the administrative and technical proficiencies around the responsibility given by law.
6 The graduates will be able to organize pharmacies and other pharmaceutical applications according to the rules.
7 The graduates will understand and successfully take part in every stage from design of pharmaceutical products to their marketing.
8 The graduates will be able to plan and perform all issues within the pharmaceutical services in the hospital.
9 The graduates will have knowledge about the obtainment, production and product technologies and production, obtainment of the natural and chemical pharmaceutical raw materials.
10 The graduates will be able to inform patients, their relatives and (patient) organizations in issues according to the safety and quality of natural products.
11 The graduates will be able to recognize plants with medical, economic and toxic potential.
12 The graduates shall know and will be able to take part in quality assurance.
13 The graduates shall know and successfully take part in the production and development of the biotechnological and radiopharmaceutical products.
14 The graduates will know the drug licensing policies, data protection, and evaluates the relationship between patent issues.
15 The graduates shall comprehend the issues of drug recognition, ensuring of drug quality, drug control and standardization.
16 The graduates shall know the therapeutic effects of the effective substances of drug and solves problems related to drug such as pharmacokinetic properties and stability
17 The graduates will be able to advice on intelligent and safe use of drugs, and they will assist in pharmacovigilance applications.
18
The graduates will know the major determinants of the extent and kinetics of drug and drug product instability (e.g., temperature, humidity, light, pH, oxygen, free radicals) and the common types of reactions (and their mechanisms) which influence drug and drug product stability (e.g., hydrolysis, oxidation, cyclization, racemization)
19 The graduates will be able to set-up and perform an (scientific) experiment, collect data, evaluate the results and to resolve the problems in the laboratory.
20 The graduates will be able to follow and acquire scientific and technological knowledge and improvements
21 The graduates will be able to control the physical, chemical, biological, toxicological and pharmaceutical characteristics of nanoformulations.
22 The graduates will have knowledge about the mechanism of actions of drugs, their side effects and the benefits of using controlled release and/or nanoformulations to increase the effects of drugs.
23 The graduates will become familiar with pharmaceutical data bases and knows how to use them to determine the state of the art of all pharmaceutical technologies.
contribution level: 1 (low) – 5 (high)
ECTS – workload table
Activity Number Time (hour) Total workload
Class Hours 15 4 60
Other Applications 0 0 0
Mid-term Examinations (including time for
preparation) 1 5 5
Quiz 2 2 4
Term Paper/ Project 0 0 0
Portfolio Study 0 0 0
Reports 0 0 0
Learning Diary 0 0 0
Thesis/ Project 0 0 0
Seminar 0 0 0
Other 0 0 0
Working Hours out of Class 8 4 32
Assignments 0 0 0
Presentation 0 0 0
Final Examinations (including preparatory
year) 1 10 10
Project 0 0 0
Clinical Practice 0 0 0
Laboratory 0 0 0
Field Work 0 0 0
Total Workload 111
Total Workload / 25 4.44
ECTS Credit of Course 4
Pharmacology I (EF2254)
ECTS: 4 3 h/w theory Period: Feb - June
Coordinator: Atilla Akdemir, PhD
Course objective: We will deepen our knowledge of the important proteins (such as enzymes and receptors) and pharmacokinetics and pharmacodynamics. We will discuss several mechanisms of important diseases. Course contents: G-protein coupled receptors; ligand-gated ion channels; voltage-gated ion channels; receptor
tyrosine kinases; nuclear receptors; enzymes, intracellular signaling pathways; membrane potential; action potential generation and propagation; muscle contraction (smooth, heart, muscle); neurotransmission; autonomic nervous system; parasympathetic nervous system; sympathetic nervous system; neurotransmitter release; cholinergic system; noradrenergic system Learning outcomes: The students:
will be able to discuss the structure, function and signaling cascades linked to GPCRs,
LGICs, VGICs, RTKs, NRs and enzymes will be able to discuss the functioning of excitable cells and muscle cells will be able to discuss the functioning of the autonomous nervous system will be able to discuss the cholinergic and noradrenergic systems will be able to discuss the serotoninergic, histaminergic systems
will be able to discuss NO, cannabinoids, purines and cytokines related signaling Form of tuition: Lectures, tutorials and self-study Course material: Powerpoint presentations, internet, text book
Literature: Rang and Dale’s Pharmacology, International Edition, Seventh Edition, Elsevier Churchill Livingstone
Entry requirements: EF1254
Course contents per week
Course contents – lectures Week Contents
1 Receptors and enzymes as drug targets
2 Chemical mediators and the autonomous nervous system
3 Cholinergic transmission
4 Cholinergic transmission
5 Noradrenergic transmission
6 Noradrenergic transmission
7 Serotoninergic transmission
8 Serotoninergic transmission
9 Histaminergic transmission
10 Histaminergic transmission
11 Nitric oxide as a messenger
12 Nitric oxide as a messenger
13 Cannabinoids
14 Purines
15 Cytokines
Assessment and evaluation system
Mid-term study Number Contribution (%)
Quiz
Project
Reports
Seminar
Assignments
Presentation
Laboratory
Field work
Total
Contribution of mid-term studies to pass mark
40
Contribution of final exam to pass mark
60
Relationship between the learning outcomes of the course and the programme outcomes
No Programme outcomes 1 2 3 4 5
1 The graduates shall know the historical developments, the importance and characteristics of pharmacies in the world and Turkey. The graduates shall know the national and international healthcare related organizations.
x
2 The graduates shall know the ethical and legal principles in the field of pharmacy and pharmaceutical sciences.
X
3 The graduates will be able to communicate health-related subjects and drug-related information to patients, health professionals and other parties.
X
4 The graduates will be able to follow, understand and apply the latest developments in pharmacies and pharmaceutical sciences.
X
5 The graduates will have the administrative and technical proficiencies around the responsibility given by law.
X
6 The graduates will be able to organize pharmacies and other pharmaceutical applications according to the rules.
X
7 The graduates will understand and successfully take part in every stage from design of pharmaceutical products to their marketing.
X
8 The graduates will be able to plan and perform all issues within the pharmaceutical services in the hospital.
X
9 The graduates will have knowledge about the obtainment, production and product technologies and production, obtainment of the natural and chemical pharmaceutical raw materials.
X
10 The graduates will be able to inform patients, their relatives and (patient) organizations in issues according to the safety and quality of natural products.
X
11 The graduates will be able to recognize plants with medical, economic and toxic potential.
X
12 The graduates shall know and will be able to take part in quality assurance. X
13 The graduates shall know and successfully take part in the production and development of the biotechnological and radiopharmaceutical products.
X
14 The graduates will know the drug licensing policies, data protection, and evaluates the relationship between patent issues.
X
15 The graduates shall comprehend the issues of drug recognition, ensuring of drug quality, drug control and standardization.
X
16 The graduates shall know the therapeutic effects of the effective substances of drug and solves problems related to drug such as pharmacokinetic properties and stability
x
17 The graduates will be able to advice on intelligent and safe use of drugs, and they will assist in pharmacovigilance applications.
X
18
The graduates will know the major determinants of the extent and kinetics of drug and drug product instability (e.g., temperature, humidity, light, pH, oxygen, free radicals) and the common types of reactions (and their mechanisms) which influence drug and drug product stability (e.g., hydrolysis, oxidation, cyclization, racemization)
X
19 The graduates will be able to set-up and perform an (scientific) experiment, collect data, evaluate the results and to resolve the problems in the laboratory.
X
20 The graduates will be able to follow and acquire scientific and technological knowledge and improvements
X
21 The graduates will be able to control the physical, chemical, biological, toxicological and pharmaceutical characteristics of nanoformulations.
X
22 The graduates will have knowledge about the mechanism of actions of drugs, their side effects and the benefits of using controlled release and/or nanoformulations to increase the effects of drugs.
X
23 The graduates will become familiar with pharmaceutical data bases and knows how to use them to determine the state of the art of all pharmaceutical technologies.
x
contribution level: 1 (low) – 5 (high)
ECTS – workload table
Activity Number Time (hour) Total workload Class Hours 15 3 45
Other Applications
Final Examinations (including preparatory year) 1 2 2
Quiz
Term Paper/ Project
Portfolio Study
Reports
Learning Diary
Thesis/ Project
Seminar
Other
Working Hours out of Class 15 3 45
Assignments
Presentation
Mid-term Examinations (including time for preparation)
1 10 10
Project
Clinical Practice
Laboratory
Field Work
Total Workload 102
Total Workload / 25 4.08
ECTS Credit of Course 4
Introduction to Pharmaceutical Technology (EF2258)
ECTS: 3 2 h/w theory Period: Feb - June
Coordinator: Fatemeh Bahadori, PhD
Course objective:
At the end of this course, students will know the basic calculations in Pharmaceutical
Technology, applications and techniques.
Course contents:
Definition of drugs and the introduction of application forms, the basic calculations used
in pharmaceutical technology, processes and techniques, drug-related phase diagrams,
solubility, solutions, physical and kinetic etc. properties. Distilled water and preparation
methods for pharmaceutical purposes.
Learning outcomes:
To train students who are aware of the technologies which are used in pharmaceutical
and scientific developments and to teach them how to combine the knowledge obtained
from literature with laboratory experience and apply it to industry. To teach the basic
rules of pre formulations and to make sure that the graduates will be aware of safety
rules for human health and the environment during research and industrial applications.
Form of tuition:
Lectures, tutorials, self-study
Course material:
Powerpoint presentations
Literature:
An introduction to pharmaceutical formulation, A. G. Fishburn
Pharmaceutical Biotechnology:An Introduction for Pharmacists and Pharmaceutical
Scientists, Daan J. A. Crommelin, Robert D. Sindelar
Modern Farmasötik Teknoloji, TEB Eczacılık Akademisi
Entry requirements:
None
Course contents per week
Course contents – lectures
Week Contents
1 Definition of Pharm. Tech. Definition of drug, information about the codex and pharmacopoeia
2 The classification of drugs according to their formulations, applications and usage.
3 The classification of drugs according to their formulations, applications and usage.
4 Introduction to Pre-formulation
5 Definition of pre-formulation
6 Tests related to pre-formulation and the benefits of pre-formulation
7 Solvents and drugs in solvent forms
8 Semi-solid drugs, ointments and pomades,
creams, gels and colloidal systems.
9 Semi-solid drugs, enema and its applications
10 The basic procedures in drug production, drying, weighing, distillation
11 The basic procedures in drug production, mixing, sieving and filtration
12 The basic procedures in drug production, extraction, drugs produced by extraction
13 Information about prescription and prescription interpretation
14 Drug delivery systems
15 Nano- drug delivery systems
Course contents – practical courses
Week Contents
1
Assessment and evaluation system
Mid-term study Number Contribution (%)
Mid-term exam 1 50
Quiz 2 40
Project - -
Reports - -
Seminar - -
Assignments 2 10
Presentation - -
Laboratory - -
Field work - -
Total 5 100
Contribution of mid-term
studies to pass mark
(%)
- 40
Contribution of final
exam to pass mark (%)
- 60
Total 100
Relationship between the learning outcomes of the course and the programme outcomes
No Programme outcomes 1 2 3 4 5
1 The graduates shall know the historical developments, the importance and characteristics of pharmacies in the world and Turkey. The graduates shall know the national and international healthcare related organizations.
X
2 The graduates shall know the ethical and legal principles in the field of pharmacy and pharmaceutical sciences.
X
3 The graduates will be able to communicate health-related subjects and drug-related information to patients, health professionals and other parties.
X
4 The graduates will be able to follow, understand and apply the latest developments in pharmacies and pharmaceutical sciences.
X
5 The graduates will have the administrative and technical proficiencies around the responsibility given by law.
X
6 The graduates will be able to organize pharmacies and other pharmaceutical applications according to the rules.
X
7 The graduates will understand and successfully take part in every stage from design of pharmaceutical products to their marketing.
X
8 The graduates will be able to plan and perform all issues within the pharmaceutical services in the hospital.
X
9 The graduates will have knowledge about the obtainment, production and product technologies and production, obtainment of the natural and chemical pharmaceutical raw materials.
X
10 The graduates will be able to inform patients, their relatives and (patient) organizations in issues according to the safety and quality of natural products.
X
11 The graduates will be able to recognize plants with medical, economic and toxic potential.
X
12 The graduates shall know and will be able to take part in quality assurance. X
13 The graduates shall know and successfully take part in the production and development of the biotechnological and radiopharmaceutical products.
X
14 The graduates will know the drug licensing policies, data protection, and evaluates the relationship between patent issues.
X
15 The graduates shall comprehend the issues of drug recognition, ensuring of drug quality, drug control and standardization.
X
16 The graduates shall know the therapeutic effects of the effective substances of drug and solves problems related to drug such as pharmacokinetic properties and stability
X
17 The graduates will be able to advice on intelligent and safe use of drugs, and they will assist in pharmacovigilance applications.
X
18
The graduates will know the major determinants of the extent and kinetics of drug and drug product instability (e.g., temperature, humidity, light, pH, oxygen, free radicals) and the common types of reactions (and their mechanisms) which influence drug and drug product stability (e.g., hydrolysis, oxidation, cyclization, racemization)
X
19 The graduates will be able to set-up and perform an (scientific) experiment, collect data, evaluate the results and to resolve the problems in the laboratory.
X
20 The graduates will be able to follow and acquire scientific and technological knowledge and improvements
X
21 The graduates will be able to control the physical, chemical, biological, toxicological and pharmaceutical characteristics of nanoformulations.
X
22 The graduates will have knowledge about the mechanism of actions of drugs, their side effects and the benefits of using controlled release and/or nanoformulations to increase the effects of drugs.
X
23 The graduates will become familiar with pharmaceutical data bases and knows how to use them to determine the state of the art of all pharmaceutical technologies.
X
contribution level: 1 (low) – 5 (high)
ECTS – workload table
Activity Number Time (hour) Total workload
Class Hours 15 2 30
Other Applications 0 0 0
Mid-term Examinations (including time for
preparation) 1 5 5
Quiz 2 3 6
Term Paper/ Project 0 0 0
Portfolio Study 0 0 0
Reports 0 0 0
Learning Diary 0 0 0
Thesis/ Project 0 0 0
Seminar 0 0 0
Other 0 0 0
Working Hours out of Class 7 3 21
Assignments 2 2 4
Presentation 0 0 0
Final Examinations (including preparatory
year) 1 10 10
Project 0 0 0
Clinical Practice 0 0 0
Laboratory 0 0 0
Field Work 0 0 0
Total Workload 76
Total Workload / 25 3,04
ECTS Credit of Course 3
Third year courses
Pharmacology II (EF3154)
ECTS: 4 3 h/w theory Period: Sep - Jan
Coordinator: Atilla Akdemir, PhD
Course objective: Providing a basic understanding of important diseases and the mechanisms of actions of selected drugs. Course contents: Pathophysiology of important diseases and action mechanisms of applied drugs: cancer, inflammation, neurological disorders, cardiovascular disorders, viral and bacterial infections, HIV
and AIDS. Drugs that are active in the immune system, histamine and antihistaminic drugs. Learning outcomes: The students:
will be able to discuss the cardiovascular system, the diseases that occur and the drugs that exists
will be able to discuss anti-inflammatory and immunosuppressant drugs
will be able to discuss neurodegenerative diseases and the existing drug treatments will be able to discuss general anaesthetic agents will be able to discuss diabetus and the existing drug treatments will be able to discuss cancer and aids the existing drug treatments
Form of tuition: Lectures, tutorials and self-study Course material: Powerpoint presentations, internet, text book Literature:
Rang and Dale’s Pharmacology, International Edition, Seventh Edition, Elsevier Churchill Livingstone
Entry requirements: EF2254
Course contents per week
Course contents – lectures Week Contents
1 Cardiovascular system
2 Cardiovascular system
3 Atherosclerosis and lipoprotein metabolism
4 Atherosclerosis and lipoprotein metabolism
5 Anti-inflammatory and immunosuppressant drugs
6 Anti-inflammatory and immunosuppressant drugs
7 The control of blood glucose and drug treatment of diabetus mellitus
8 The nervous system
9 Neurodegenerative diseases
10 Neurodegenerative diseases
11 General anaesthetic agents
12 Cancer
13 Cancer
14 AIDS
15 AIDS
Assessment and evaluation system
Mid-term study Number Contribution (%)
Quiz
Project
Reports
Seminar
Assignments
Presentation
Laboratory
Field work
Total
Contribution of mid-term studies to pass mark
40
Contribution of final exam to pass mark
60
Relationship between the learning outcomes of the course and the programme outcomes
No Programme outcomes 1 2 3 4 5
1 The graduates shall know the historical developments, the importance and characteristics of pharmacies in the world and Turkey. The graduates shall know the national and international healthcare related organizations.
X
2 The graduates shall know the ethical and legal principles in the field of pharmacy and pharmaceutical sciences.
X
3 The graduates will be able to communicate health-related subjects and drug-related information to patients, health professionals and other parties.
X
4 The graduates will be able to follow, understand and apply the latest developments in pharmacies and pharmaceutical sciences.
X
5 The graduates will have the administrative and technical proficiencies around the responsibility given by law.
X
6 The graduates will be able to organize pharmacies and other pharmaceutical applications according to the rules.
X
7 The graduates will understand and successfully take part in every stage from design of pharmaceutical products to their marketing.
X
8 The graduates will be able to plan and perform all issues within the pharmaceutical services in the hospital.
X
9 The graduates will have knowledge about the obtainment, production and product technologies and production, obtainment of the natural and chemical pharmaceutical raw materials.
X
10 The graduates will be able to inform patients, their relatives and (patient) organizations in issues according to the safety and quality of natural products.
X
11 The graduates will be able to recognize plants with medical, economic and toxic potential.
X
12 The graduates shall know and will be able to take part in quality assurance. X
13 The graduates shall know and successfully take part in the production and development of the biotechnological and radiopharmaceutical products.
X
14 The graduates will know the drug licensing policies, data protection, and evaluates the relationship between patent issues.
X
15 The graduates shall comprehend the issues of drug recognition, ensuring of drug quality, drug control and standardization.
X
16 The graduates shall know the therapeutic effects of the effective substances of drug and solves problems related to drug such as pharmacokinetic properties and stability
X
17 The graduates will be able to advice on intelligent and safe use of drugs, and they will assist in pharmacovigilance applications.
X
18
The graduates will know the major determinants of the extent and kinetics of drug and drug product instability (e.g., temperature, humidity, light, pH, oxygen, free radicals) and the common types of reactions (and their mechanisms) which influence drug and drug product stability (e.g., hydrolysis, oxidation, cyclization, racemization)
X
19 The graduates will be able to set-up and perform an (scientific) experiment, collect data, evaluate the results and to resolve the problems in the laboratory.
X
20 The graduates will be able to follow and acquire scientific and technological knowledge and improvements
X
21 The graduates will be able to control the physical, chemical, biological, toxicological and pharmaceutical characteristics of nanoformulations.
X
22 The graduates will have knowledge about the mechanism of actions of drugs, their side effects and the benefits of using controlled release and/or nanoformulations to increase the effects of drugs.
X
23 The graduates will become familiar with pharmaceutical data bases and knows how to use them to determine the state of the art of all pharmaceutical technologies.
x
contribution level: 1 (low) – 5 (high)
ECTS – workload table
Activity Number Time (hour) Total workload Class Hours 15 3 45
Other Applications
Final Examinations (including preparatory year) 1 2 2
Quiz
Term Paper/ Project
Portfolio Study
Reports
Learning Diary
Thesis/ Project
Seminar
Other
Working Hours out of Class 15 3 45
Assignments
Presentation
Mid-term Examinations (including time for preparation)
1 10 10
Project
Clinical Practice
Laboratory
Field Work
Total Workload 102
Total Workload / 25 4.08
ECTS Credit of Course 4
Pharmaceutical Technology I (EF3158)
ECTS: 4 3 h/w theory; 2 h/w practice Period: Sep - Jan
Coordinator: Fatemeh Bahadori, PhD
Course objective:
Students will learn about semi solid dosages, double phase systems and their functions
Course contents:
Preparation and usage of aromatic waters and syrups; potions, lemonades, merlits,
elixirs, the solutions that don’t have water as the major solute (syrup, potion, glyceres,
collutuars, lotions and enema), water (distilled and deionized water), solution (solubility
conditions and kinetics), and rheology, aerosols, macromolecules, colloids, suspensions,
emulsions.
Learning outcomes:
To train students who are aware of the technologies which are used in pharmaceutical
and scientific developments specially the semi-solid and colloidal ones and to teach them
how to combine the knowledge obtained from literature with laboratory experience and
apply it to the development of semi-solid formulations.
Form of tuition:
Lectures, tutorials and self-study
Course material:
Powerpoint presentations
Literature:
Current Research in Pharmaceutical Technology, Sabine Globig,William Hunter, Jr
Experimental pharmaceutical technology, Eugene L. Parrott, Witold Saski
Pharmaceutical Biotechnology:An Introduction for Pharmacists and Pharmaceutical
Scientists, Daan J. A. Crommelin, Robert D. Sindelar
Modern Farmasötik Teknoloji, TEB Eczacılık Akademisi
Entry requirements:
EF 2258
Course contents per week
Course contents – lectures
Week Contents
1 Definition of standards, preparation of standards and harmonize them with the current rules
2 Definition of pharmaceutical water forms and its key role in pharmaceutical applications. Preparation of distilled water, introduction of water reservoirs and its delivery systems.
Validation methods of water systems and definition of quality control methods of
pharmaceutical waters.
3 The discussion of the dosage forms together with their applications and the resulted therapeutic effects. Application of physicochemical and biopharmaceutical rules to dosage forms.
4 Biopharmaceutical evaluations of pharmaceutical dosage forms and their
applications in design of different dosage forms
5 Definition of solutions, introduction to the solutions available in the market, advantage and dis-advantages of solution forms, definition of aqueous and dry dosage forms
6 Methods used in preparation of solutions, quality control and stability tests for solutions. Preparation of solutions and their labelling
7 The theory of disperse systems, intra-face circumstances, the electro-kinetic and rheological specifications of colloidal and rough dispersions. Definition of colloidal systems and intra-face events and their application to pharmaceutical productions.
8 Explanation of physical characteristics of suspensions, definition of flocculation and aggregation. The effects of viscosity on the sedimentation of suspensions.
9 Definition of emulsions and emulsion makers. The two most important factors in in definition of emulsion types; (o/w vs. w/o).
10 Definition of the instability levels related to emulsions. The methods for stabilizing the emulsions. The HLB (Hydrophilic, Lipophilic Balance) calculations for emulsions.
11 The classification of ointment based drug dosages. Their physical properties and the best usage form definitions
12 Integration of the solid drugs to the ointment bases and their different applications. The relation between the ointment ingredients and the release period.
13 The definition of suppositories, explanation of their size and applications, advantage and dis-advantages and related ingredients. Packing and storage conditions, quality control tests and the suggestions for patient for maximum efficacy
14 Definition of aerosols, their ingredients and their advantage and disadvantages. Definition of container, valve, propellant and product concentration which is used inn production of aerosols. Packing, storage and usage conditions.
15 Transdermal dosage forms, transdermal patch systems, their ingredients, advantages and dis advantages.
Course contents – practical courses
Week Contents
1 Preparation of topical solvent formulations
2 Preparation of topical solvent formulations
3 Preparing syrup formulations in small scale
4 Preparing syrup formulations in small scale
5 Preparation of topical suspensions and their labelling
6 Investigation of the rheological properties of the suspensions
7 Preparation of oral suspensions and their labelling
8 The methods used in preparation of emulsions
9 The methods used in preparation of ointments
10 The methods used in preparation of ointments
11 Preparation of suppositories
12 Stability tests
13 Stability tests
14 Make up
15 Make up
Assessment and evaluation system
Mid-term study Number Contribution (%)
Mid-term exam 1 50
Quiz - -
Project - -
Reports - -
Seminar - -
Assignments - -
Presentation - -
Laboratory 2 25
Field work - -
Total 3 100
Contribution of mid-term
studies to pass mark
(%)
- 40
Contribution of final
exam to pass mark (%)
- 60
Total - 100
Relationship between the learning outcomes of the course and the programme outcomes
No Programme outcomes 1 2 3 4 5
1 The graduates shall know the historical developments, the importance and characteristics of pharmacies in the world and Turkey. The graduates shall know the national and international healthcare related organizations.
X
2 The graduates shall know the ethical and legal principles in the field of pharmacy and pharmaceutical sciences.
X
3 The graduates will be able to communicate health-related subjects and drug-related information to patients, health professionals and other parties.
X
4 The graduates will be able to follow, understand and apply the latest developments in pharmacies and pharmaceutical sciences.
X
5 The graduates will have the administrative and technical proficiencies around the responsibility given by law.
X
6 The graduates will be able to organize pharmacies and other pharmaceutical applications according to the rules.
X
7 The graduates will understand and successfully take part in every stage from design of pharmaceutical products to their marketing.
X
8 The graduates will be able to plan and perform all issues within the pharmaceutical services in the hospital.
X
9 The graduates will have knowledge about the obtainment, production and product technologies and production, obtainment of the natural and chemical pharmaceutical raw materials.
X
10 The graduates will be able to inform patients, their relatives and (patient) organizations in issues according to the safety and quality of natural products.
X
11 The graduates will be able to recognize plants with medical, economic and toxic potential.
X
12 The graduates shall know and will be able to take part in quality assurance. X
13 The graduates shall know and successfully take part in the production and development of the biotechnological and radiopharmaceutical products.
X
14 The graduates will know the drug licensing policies, data protection, and evaluates the relationship between patent issues.
X
15 The graduates shall comprehend the issues of drug recognition, ensuring of drug quality, drug control and standardization.
X
16 The graduates shall know the therapeutic effects of the effective substances of drug and solves problems related to drug such as pharmacokinetic properties and stability
X
17 The graduates will be able to advice on intelligent and safe use of drugs, and they will assist in pharmacovigilance applications.
X
18
The graduates will know the major determinants of the extent and kinetics of drug and drug product instability (e.g., temperature, humidity, light, pH, oxygen, free radicals) and the common types of reactions (and their mechanisms) which influence drug and drug product stability (e.g., hydrolysis, oxidation, cyclization, racemization)
X
19 The graduates will be able to set-up and perform an (scientific) experiment, collect data, evaluate the results and to resolve the problems in the laboratory.
X
20 The graduates will be able to follow and acquire scientific and technological knowledge and improvements
X
21 The graduates will be able to control the physical, chemical, biological, toxicological and pharmaceutical characteristics of nanoformulations.
X
22 The graduates will have knowledge about the mechanism of actions of drugs, their side effects and the benefits of using controlled release and/or nanoformulations to increase the effects of drugs.
X
23 The graduates will become familiar with pharmaceutical data bases and knows how to use them to determine the state of the art of all pharmaceutical technologies.
X
contribution level: 1 (low) – 5 (high)
ECTS – workload table
Activity Number Time (hour) Total workload
Class Hours 15 3 45
Other Applications 0 0 0
Mid-term Examinations (including time for
preparation) 1 5 5
Quiz 0 0 0
Term Paper/ Project 0 0 0
Portfolio Study 0 0 0
Reports 0 0 0
Learning Diary 0 0 0
Thesis/ Project 0 0 0
Seminar 0 0 0
Other 0 0 0
Working Hours out of Class 7 3 21
Assignments 0 0 0
Presentation 0 0 0
Final Examinations (including preparatory
year) 1 10 10
Project 0 0 0
Clinical Practice 0 0 0
Laboratory 15 2 30
Field Work 0 0 0
Total Workload 111
Total Workload / 25 4.44
ECTS Credit of Course 4
Pharmaceutical Chemistry I (EF3161)
ECTS: 4 3 h/w theory; 2 h/w practice Period: Sep - Jan
Coordinator: Binnur Temel, PhD
Course objective:
At the end of this course, the students should be able to: a) detect the relationship
between physicochemical properties and activity of different drugs, b) understand how
drugs function on the molecular level (mechanism of action), c) study the concepts of
drug latentiation and pro-drug formation, d) know some drug classes including
preparation, identity assay procedures, e) qualitatively analyse some of the studied
pharmaceutical substances, and f) perform different chemical limit tests according to
pharmacopeia requirements.
Course contents:
Factors that affect drug activities, physicochemical factors (solubility, ionization and
steric factors), chemical properties, chemical bonds, structural characteristics,
contribution of some functional groups to the biological effects, definition of isoster and
bioisosterism.
Learning outcomes:
To prepare students who are aware of the pharmaceutical and scientific developments in
related fields and will combine knowledge and creativity gained in education, to
contribute to the academia, community or industry. To provide the students with the
skills needed for the synthesis and purification of organic molecules in the laboratory. To
teach strict rules which to ensure conditions are safe for human health and the
environment during these applications.
Form of tuition:
Lectures, tutorials, laboratory and self-study
Course material:
Powerpoint presentations
Literature:
Medicinal Chemistry An Introduction, 2nd Edition by Gareth Thomas
Medicinal Chemistry, A Biochemical Approach, T.Nogrady
An Introduction to Medicinal Chemistry, G.L.Patrick
Foye’s Principle of Medicinal Chemistry, D.A.Williams, T.L.Lemke
Textbook of Organic Medicinal and Pharmaceutical Chemistry, J.N.Delgado, W.A.Remers
The Practice of Medicinal Chemistry, C.G.Wermuth
Entry requirements:
None
Course contents per week
Course contents – lectures
Week Contents
1 Pharmaceutical chemistry within the
framework of pharmacy education, sources
of drugs
2 Drug development, structure-activity
relationships, isosterism
3 Bioisosterism, factors effecting biological
activity,protein binding,solubility, patition
coefficient, acids and bases
4 Ionization constant (pKa), Handerson -
Hasselbach equation, inductive and
resonance effects
5 Electronic substituent constant,Hammet
equation, reaction constant
6 Quantitative structure activity relations,
interpretation of the equations,
7 Biological membranes, drug targets,
receptor types
8 Bonds in drug receptor interactions,
covalent bonds
9 Isomerism in drug receptor interactions,
enzymes
10 Nucleic acids,the chemistry of drug
metabolism and excretion, phase I
reactions
11 Oxidation, reduction, hydrolysis
12 Prodrugs,hard and soft drugs
13 Antibacterial agents
14 The peripheral nervous system-
cholinergics, anticholinergics, and
anticholineesterases
15 The peripheral nervous system-
cholinergics, anticholinergics, and
anticholineesterases
Course contents – practical courses
Week Contents
1 Physical and chemical methods in drug
synthesis
2 Physical and chemical methods in drug
synthesis
3 Distillation, extraction,
recrystallization,filtration
4 Distillation, extraction,
recrystallization,filtration
5 Nitration,halogenation,diazotization,
acylation, condensation,reduction,
oxidation,esterification, hydrolysis
6 Nitration,halogenation,diazotization,
acylation, condensation,reduction,
oxidation,esterification, hydrolysis
7 Nitration,halogenation,diazotization,
acylation, condensation,reduction,
oxidation,esterification, hydrolysis
8 Nitration,halogenation,diazotization,
acylation, condensation,reduction,
oxidation,esterification, hydrolysis
9 Nitration,halogenation,diazotization,
acylation, condensation,reduction,
oxidation,esterification, hydrolysis
10 Nitration,halogenation,diazotization,
acylation, condensation,reduction,
oxidation,esterification, hydrolysis
11 Nitration,halogenation,diazotization,
acylation, condensation,reduction,
oxidation,esterification, hydrolysis
12 Nitration,halogenation,diazotization,
acylation, condensation,reduction,
oxidation,esterification, hydrolysis
13 Nitration,halogenation,diazotization,
acylation, condensation,reduction,
oxidation,esterification, hydrolysis
14 Make-up
15 Make-up
Assessment and evaluation system
Mid-term study Number Contribution (%)
Mid-term exam 1 55
Quiz - -
Project - -
Reports - -
Seminar - -
Assignments - -
Presentation - -
Laboratory 9 5
Field work - -
Total 3 100
Contribution of mid-term
studies to pass mark
(%)
- 40
Contribution of final
exam to pass mark (%)
- 60
Total 100
Relationship between the learning outcomes of the course and the programme
outcomes
No Programme outcomes 1 2 3 4 5
1
The graduates shall know the historical developments, the
importance and characteristics of pharmacies in the world and
Turkey. The graduates shall know the national and international
healthcare related organizations.
2 The graduates shall know the ethical and legal principles in the field
of pharmacy and pharmaceutical sciences.
3
The graduates will be able to communicate health-related subjects
and drug-related information to patients, health professionals and
other parties.
4 The graduates will be able to follow, understand and apply the
latest developments in pharmacies and pharmaceutical sciences.
5 The graduates will have the administrative and technical
proficiencies around the responsibility given by law.
6 The graduates will be able to organize pharmacies and other
pharmaceutical applications according to the rules.
7 The graduates will understand and successfully take part in every
stage from design of pharmaceutical products to their marketing.
8 The graduates will be able to plan and perform all issues within the
pharmaceutical services in the hospital.
9
The graduates will have knowledge about the obtainment,
production and product technologies and production, obtainment of
the natural and chemical pharmaceutical raw materials.
10
The graduates will be able to inform patients, their relatives and
(patient) organizations in issues according to the safety and quality
of natural products.
11 The graduates will be able to recognize plants with medical,
economic and toxic potential.
12 The graduates shall know and will be able to take part in quality
assurance.
13
The graduates shall know and successfully take part in the
production and development of the biotechnological and
radiopharmaceutical products.
14 The graduates will know the drug licensing policies, data protection,
and evaluates the relationship between patent issues.
15 The graduates shall comprehend the issues of drug recognition,
ensuring of drug quality, drug control and standardization.
16
The graduates shall know the therapeutic effects of the effective
substances of drug and solves problems related to drug such as
pharmacokinetic properties and stability
17 The graduates will be able to advice on intelligent and safe use of
drugs, and they will assist in pharmacovigilance applications.
18
The graduates will know the major determinants of the extent and
kinetics of drug and drug product instability (e.g., temperature,
humidity, light, pH, oxygen, free radicals) and the common types of
reactions (and their mechanisms) which influence drug and drug
product stability (e.g., hydrolysis, oxidation, cyclization,
racemization)
19
The graduates will be able to set-up and perform an (scientific)
experiment, collect data, evaluate the results and to resolve the
problems in the laboratory.
20 The graduates will be able to follow and acquire scientific and
technological knowledge and improvements
21 The graduates will be able to control the physical, chemical,
biological, toxicological and pharmaceutical characteristics of
nanoformulations.
22
The graduates will have knowledge about the mechanism of actions
of drugs, their side effects and the benefits of using controlled
release and/or nanoformulations to increase the effects of drugs.
23
The graduates will become familiar with pharmaceutical data bases
and knows how to use them to determine the state of the art of all
pharmaceutical technologies.
contribution level: 1 (low) – 5 (high)
ECTS – workload table
Activity Number Time (hour) Total workload
Class Hours 15 3 45
Other Applications 0 0 0
Mid-term Examinations (including time for
preparation) 1 5 5
Quiz 0 0 0
Term Paper/ Project 0 0 0
Portfolio Study 0 0 0
Reports 0 0 0
Learning Diary 0 0 0
Thesis/ Project 0 0 0
Seminar 0 0 0
Other 0 0 0
Working Hours out of Class 7 3 21
Assignments 0 0 0
Presentation 0 0 0
Final Examinations (including preparatory
year) 1 10 10
Project 0 0 0
Clinical Practice 0 0 0
Laboratory 15 2 30
Field Work 0 0 0
Total Workload 111
Total Workload / 25 4.44
ECTS Credit of Course 4
Pharmaceutical Technology II (EF3258)
ECTS: 4 3 h/w theory; 2 h/w practice Period: Feb - June
Coordinator: Fatemeh Bahadori, PhD
Course objective:
The aim of this course is to understand the applications of Pharmaceutical technology in
the areas rather than medicine preparation such as preparation of hygiene products
Course contents:
Preparation of pharmaceuticals, physical, chemical and microbiological controls, in vivo
and in vitro experiments, suppository (general information and control of ointments,
preparation and control of suppositories), preparation of ovules, surgical materials
(gauze, cotton, plaster, etc.), paste, tooth paste, soap, radiopharmaceuticals, colorants
and antioxidants, parenteral solutions, ophtalmologic preparations (preparation and
sterilization of eye drops).
Learning outcomes:
To train students who are aware of the technologies which are used in pharmaceutical
procedures like sterilization. To teach them how to apply pharmaceutical sciences to
areas other than pharmacy practice
Form of tuition:
Lectures, tutorials and self-study
Course material:
Powerpoint presentations
Literature:
Current Research in Pharmaceutical Technology, Sabine Globig,William Hunter, Jr
Experimental pharmaceutical technology, Eugene L. Parrott, Witold Saski
Pharmaceutical Biotechnology:An Introduction for Pharmacists and Pharmaceutical
Scientists, Daan J. A. Crommelin, Robert D. Sindelar
Modern Farmasötik Teknoloji, TEB Eczacılık Akademisi
Entry requirements:
None
Course contents per week
Course contents – lectures
Week Contents
1 isotonicity calculations and preparation of ophthalmic propagates. Tampons, tampon
capacity, isoosmotics, isoosmotic pressure and definition of hypertonicity and hypotonicity. The
pH area acceptable for ophthalmic solutions.
2 Tampons are used in preparation of ophthalmological solutions with the desired pH
and isotonicity, the importance of isotonicity in the ophthalmic preparations.
3 Preparation of nasal and otic preparations, the importance of sterilization in the preparation of otic and nasal formulations
4 Explanation of microbial contamination sources, introduction of the methods used in minimising
the microbial contaminations, microbial quality controls, disinfectants. Antiseptic applications and sterilization, the efficacy tests for the protectants. Sterilization methods, autoclaves, dry air sterilizations.
5 Sterilization by radiation, sterilization via filtration, sterilization by chemical methods. To select the best sterilization method. The safety of sterilization method, the sterilized dosages used in pharmacology.
6 A short history of parenteral preparations, parenteral application methods, production techniques and the necessary aseptic techniques. The calculations related to parenteral preparations.
7 The explanations about the decision procedure need to be done for parenteral dosages, the clean room definitions and the quantification tests like pyrogen test, clarity test and particle analysis
8 Parenteral solvents in bulk volumes, total parenteral feeding, irrigation solvents
9 Pharmaceutical powders, particle properties, the properties of powders and granules and the best ways of their applications
10 The advantages and disadvantages of tablets. The crucial USP tests for tablets and evaluation of tablets according to these results.
11 evaluation of tablets according to USP results.
12 Evaluation of tablets according to pharmacopeia
13 Advantage and disadvantages of capsules. The crucial USP tests for capsules. The methods for preparation of soft and hard capsules. Evaluation of capsules according to pharmacopeia
14 Some samples of hard and soft pastilles
15 Packing, primer and seconder packing, the importance of packing, the factors influence the selection of packing, the materials are used in different package forms.
Course contents – practical courses
Week Contents
1 Preparation of ophthalmic and nasal formulations
2 Preparation of ophthalmic and nasal formulations
3 Preparation of ophthalmic and nasal formulations
4 Preparation of sterilized parenteral formulations
5 Preparation of sterilized parenteral formulations
6 Sterilization techniques
7 Preparation of parenteral formulations in bulk volume
8 Preparation of powders, granules and effervescent tablets
9 Preparation of tablet formulations
10 Quality control of tablet formulations
11 Preparation of capsule formulations
12 Quality control of capsule formulations
13 Preparation of soft and hard pastilles
14 Make up
15 Make up
Assessment and evaluation system
Mid-term study Number Contribution (%)
Mid-term exam 1 50
Quiz - -
Project - -
Reports - -
Seminar - -
Assignments - -
Presentation - -
Laboratory 2 25
Field work - -
Total 3 100
Contribution of mid-term
studies to pass mark
(%)
- 40
Contribution of final
exam to pass mark (%)
- 60
Total - 100
Relationship between the learning outcomes of the course and the programme outcomes
No Programme outcomes 1 2 3 4 5
1 The graduates shall know the historical developments, the importance and characteristics of pharmacies in the world and Turkey. The graduates shall know the national and international healthcare related organizations.
X
2 The graduates shall know the ethical and legal principles in the field of pharmacy and pharmaceutical sciences.
X
3 The graduates will be able to communicate health-related subjects and drug-related information to patients, health professionals and other parties.
X
4 The graduates will be able to follow, understand and apply the latest developments in pharmacies and pharmaceutical sciences.
X
5 The graduates will have the administrative and technical proficiencies around the responsibility given by law.
X
6 The graduates will be able to organize pharmacies and other pharmaceutical applications according to the rules.
X
7 The graduates will understand and successfully take part in every stage from design of pharmaceutical products to their marketing.
X
8 The graduates will be able to plan and perform all issues within the pharmaceutical services in the hospital.
X
9 The graduates will have knowledge about the obtainment, production and product technologies and production, obtainment of the natural and chemical pharmaceutical raw materials.
X
10 The graduates will be able to inform patients, their relatives and (patient) organizations in issues according to the safety and quality of natural products.
X
11 The graduates will be able to recognize plants with medical, economic and toxic potential.
X
12 The graduates shall know and will be able to take part in quality assurance. X
13 The graduates shall know and successfully take part in the production and development of the biotechnological and radiopharmaceutical products.
X
14 The graduates will know the drug licensing policies, data protection, and evaluates the relationship between patent issues.
X
15 The graduates shall comprehend the issues of drug recognition, ensuring of drug quality, drug control and standardization.
X
16 The graduates shall know the therapeutic effects of the effective substances of drug and solves problems related to drug such as pharmacokinetic properties and stability
X
17 The graduates will be able to advice on intelligent and safe use of drugs, and they will assist in pharmacovigilance applications.
X
18
The graduates will know the major determinants of the extent and kinetics of drug and drug product instability (e.g., temperature, humidity, light, pH, oxygen, free radicals) and the common types of reactions (and their mechanisms) which influence drug and drug product stability (e.g., hydrolysis, oxidation, cyclization, racemization)
X
19 The graduates will be able to set-up and perform an (scientific) experiment, collect data, evaluate the results and to resolve the problems in the laboratory.
X
20 The graduates will be able to follow and acquire scientific and technological knowledge and improvements
X
21 The graduates will be able to control the physical, chemical, biological, toxicological and pharmaceutical characteristics of nanoformulations.
X
22 The graduates will have knowledge about the mechanism of actions of drugs, their side effects and the benefits of using controlled release and/or nanoformulations to increase the effects of drugs.
X
23 The graduates will become familiar with pharmaceutical data bases and knows how to use them to determine the state of the art of all pharmaceutical technologies.
X
contribution level: 1 (low) – 5 (high)
ECTS – workload table
Activity Number Time (hour) Total workload
Class Hours 15 3 45
Other Applications 0 0 0
Mid-term Examinations (including time for
preparation) 1 5 5
Quiz 0 0 0
Term Paper/ Project 0 0 0
Portfolio Study 0 0 0
Reports 0 0 0
Learning Diary 0 0 0
Thesis/ Project 0 0 0
Seminar 0 0 0
Other 0 0 0
Working Hours out of Class 7 3 21
Assignments 0 0 0
Presentation 0 0 0
Final Examinations (including preparatory
year) 1 10 10
Project 0 0 0
Clinical Practice 0 0 0
Laboratory 15 2 30
Field Work 0 0 0
Total Workload 111
Total Workload / 25 4.44
ECTS Credit of Course 4
Pharmaceutical Chemistry II (EF3261)
ECTS: 4 3 h/w theory; 2 h/w practice Period: Period: Sep - Jan
Coordinator: Binnur Temel, PhD
Course objective:
The objective of this course is to prepare the student for professional practice by
teaching the sources, nature, uses, and important chemical, biochemical and
pharmacological aspects of medicinal and pharmaceutical agents that treat or alleviate
the disorder and regain the proper function different systems of the human body.
Course contents:
Chemical properties, synthetic routes and metabolism, structure-activity relationships
of: Histamine and antihistamines, local anesthetics, analgesics and drugs acting on the
peripheral nervous system drugs (cholinergic, anticholinergic agents, adrenergics).
Drugs that affect the digestive system (emetics and anti-emetics, gastric acid-enhancing
drugs, anti-acid and medicines to prevent gastric secretion, drugs used to treat liver
disorders, cholagogues, laxative, antidiaretic drugs, endocrine system drugs, steroidal
hormones and diagnostic drugs. Antibacterial drugs (sulfonamides, urinary antibacterial
agents, antibiotics), antihelmentic and antifungal drugs, anticoagulant drugs, antitussive
drugs and anticancer drugs.
Learning outcomes:
Upon successful completion of this course the students can now understand the recent
advances in the medicinal chemistry and drug design together with the synthesis and
pharmacological profile of some selected classes of pharmaceutical agents.
Form of tuition:
Lectures, tutorials, laboratory and self-study
Course material:
PowerPoint presentations, text book and internet
Literature:
Medicinal Chemistry An Introduction, 2nd Edition by Gareth Thomas
Medicinal Chemistry, A Biochemical Approach, T.Nogrady
An Introduction to Medicinal Chemistry, G.L.Patrick
Foye’s Principle of Medicinal Chemistry, D.A.Williams, T.L.Lemke
Textbook of Organic Medicinal and Pharmaceutical Chemistry, J.N.Delgado, W.A.Remers
The Practice of Medicinal Chemistry, C.G.Wermuth
Entry requirements:
None
Course contents per week
Course contents – lectures
Week Contents
1 Sympathetic (adrenergic) system,
adrenergic agonists
2 Antihypertensive drugs,antiarrythmic and
antihyperlipidemic drugs
3 Drugs acting on coagulation mechanisms,
diuretics,antiparkisonian drugs
4 Muscle relaxants, drugs acting on the
gastro-intestinal system
5 General anesthetics,local anesthetics
6 Sedatives and hypnotics, antiepileptics
7 Antidepressants, psychoanaleptics
8 Psychoactive drugs, neuroleptics
9 Histamine and antihistaminic drugs,H1-
receptor antagonists
10 H2-receptor antagonists ,proton pump
inhibitors and inhibitors of histamine
release
11 Morphine and narcotic analgesics
12 Thyroid hormones and related drugs
13 Beta-lactam antibiotics, penicillins
14 Antifungal and antiviral drugs
15 Anticancer drugs
Course contents – practical courses
Week Contents
1 Qualitative chemical and spectral analysis
of organic compounds
2 Structure determination in organic
compounds
3 Determination of elemental composition
and solubility
4 Melting point determination
5 Functional group identification
6 UV and IR spectroscopy in structure
determination
7 Analysis of NMR and mass spectra
8 Structure determination of an unknown
using chemical and spectral methods
9 Structure determination of an unknown
using chemical and spectral methods
10 Structure determination of an unknown
using chemical and spectral methods
11 Structure determination of an unknown
using chemical and spectral methods
12 Structure determination of an unknown
using chemical and spectral methods
13 Structure determination of an unknown
using chemical and spectral methods
14 Make-up
15 Make-up
Assessment and evaluation system
Mid-term study Number Contribution (%)
Mid-term exam 1 55
Quiz - -
Project - -
Reports - -
Seminar - -
Assignments - -
Presentation - -
Laboratory 9 5
Field work - -
Total 3 100
Contribution of mid-term
studies to pass mark
(%)
- 40
Contribution of final
exam to pass mark (%)
- 60
Total 100
Relationship between the learning outcomes of the course and the programme
outcomes
No Programme outcomes 1 2 3 4 5
1
The graduates shall know the historical developments, the
importance and characteristics of pharmacies in the world and
Turkey. The graduates shall know the national and international
healthcare related organizations.
2 The graduates shall know the ethical and legal principles in the field
of pharmacy and pharmaceutical sciences.
3
The graduates will be able to communicate health-related subjects
and drug-related information to patients, health professionals and
other parties.
4 The graduates will be able to follow, understand and apply the
latest developments in pharmacies and pharmaceutical sciences.
5 The graduates will have the administrative and technical
proficiencies around the responsibility given by law.
6 The graduates will be able to organize pharmacies and other
pharmaceutical applications according to the rules.
7 The graduates will understand and successfully take part in every
stage from design of pharmaceutical products to their marketing.
8 The graduates will be able to plan and perform all issues within the
pharmaceutical services in the hospital.
9
The graduates will have knowledge about the obtainment,
production and product technologies and production, obtainment of
the natural and chemical pharmaceutical raw materials.
10
The graduates will be able to inform patients, their relatives and
(patient) organizations in issues according to the safety and quality
of natural products.
11 The graduates will be able to recognize plants with medical,
economic and toxic potential.
12 The graduates shall know and will be able to take part in quality
assurance.
13
The graduates shall know and successfully take part in the
production and development of the biotechnological and
radiopharmaceutical products.
14 The graduates will know the drug licensing policies, data protection,
and evaluates the relationship between patent issues.
15 The graduates shall comprehend the issues of drug recognition,
ensuring of drug quality, drug control and standardization.
16
The graduates shall know the therapeutic effects of the effective
substances of drug and solves problems related to drug such as
pharmacokinetic properties and stability
17 The graduates will be able to advice on intelligent and safe use of
drugs, and they will assist in pharmacovigilance applications.
18
The graduates will know the major determinants of the extent and
kinetics of drug and drug product instability (e.g., temperature,
humidity, light, pH, oxygen, free radicals) and the common types of
reactions (and their mechanisms) which influence drug and drug
product stability (e.g., hydrolysis, oxidation, cyclization,
racemization)
19
The graduates will be able to set-up and perform an (scientific)
experiment, collect data, evaluate the results and to resolve the
problems in the laboratory.
20 The graduates will be able to follow and acquire scientific and
technological knowledge and improvements
21 The graduates will be able to control the physical, chemical,
biological, toxicological and pharmaceutical characteristics of
nanoformulations.
22
The graduates will have knowledge about the mechanism of actions
of drugs, their side effects and the benefits of using controlled
release and/or nanoformulations to increase the effects of drugs.
23
The graduates will become familiar with pharmaceutical data bases
and knows how to use them to determine the state of the art of all
pharmaceutical technologies.
contribution level: 1 (low) – 5 (high)
ECTS – workload table
Activity Number Time (hour) Total workload
Class Hours 15 3 45
Other Applications 0 0 0
Mid-term Examinations (including time for
preparation) 1 5 5
Quiz 0 0 0
Term Paper/ Project 0 0 0
Portfolio Study 0 0 0
Reports 0 0 0
Learning Diary 0 0 0
Thesis/ Project 0 0 0
Seminar 0 0 0
Other 0 0 0
Working Hours out of Class 7 3 21
Assignments 0 0 0
Presentation 0 0 0
Final Examinations (including preparatory
year) 1 10 10
Project 0 0 0
Clinical Practice 0 0 0
Laboratory 15 2 30
Field Work 0 0 0
Total Workload 111
Total Workload / 25 4.44
ECTS Credit of Course 4
Fourth year courses
Drug Design and Structure-Activity Relationships (EF4168)
ECTS: 6 3 h/w theory Period: Sep - Jan
Coordinator: Atilla Akdemir, PhD
Course objective: Providing a basic understanding of drug design and development in general. Also, we will discuss computer-aided drug design and discovery procedures and SAR methods. Course contents: Introduction to drug development: target identification, target validation, hit identification, lead identification and optimization, preclinical studies, clinical studies, drug approval, marketing;
introduction to structure-activity relationships; methods for rational and computer-aided drug design and discovery; interactions between drug active substance and receptor/enzyme; sequence alignments; molecular modeling, homology models, docking, structure-based design procedures, ligand-based design procedures. Learning outcomes:
The students:
will be able to discuss the general features of drug development will be able to discuss the characteristics of a good target for drug development will be able to discuss the different procedures used for rational and computer-aided drug
design and discovery Form of tuition:
Lectures, tutorials and self-study Course material: Powerpoint presentations, internet Literature: --
Entry requirements: EF1254
Course contents per week
Course contents – lectures Week Contents
1 Introduction to drug development
2 Target identification/validation – hit finding – lead finding/optimization
3 protein structures
4 structure-activity relationships
5 structure-activity relationships
6 ligand-protein interactions
7 homology modelling
8 docking
9 QSAR
10 literature project
11 literature project 12 literature project 13 literature project 14 literature project 15 presentation
Assessment and evaluation system
Mid-term study Number Contribution (%)
Quiz
Project 1 40
Reports
Seminar
Assignments
Presentation
Laboratory
Field work
Total 40
Contribution of mid-term studies to pass mark
-
Contribution of final exam to pass mark
60
Relationship between the learning outcomes of the course and the programme outcomes
No Programme outcomes 1 2 3 4 5
1 The graduates shall know the historical developments, the importance and characteristics of pharmacies in the world and Turkey. The graduates shall know the national and international healthcare related organizations.
x
2 The graduates shall know the ethical and legal principles in the field of pharmacy and pharmaceutical sciences.
x
3 The graduates will be able to communicate health-related subjects and drug-related information to patients, health professionals and other parties.
x
4 The graduates will be able to follow, understand and apply the latest developments in pharmacies and pharmaceutical sciences.
x
5 The graduates will have the administrative and technical proficiencies around the responsibility given by law.
x
6 The graduates will be able to organize pharmacies and other pharmaceutical applications according to the rules.
x
7 The graduates will understand and successfully take part in every stage from design of pharmaceutical products to their marketing.
x
8 The graduates will be able to plan and perform all issues within the pharmaceutical services in the hospital.
x
9 The graduates will have knowledge about the obtainment, production and product technologies and production, obtainment of the natural and chemical pharmaceutical raw materials.
x
10 The graduates will be able to inform patients, their relatives and (patient) organizations in issues according to the safety and quality of natural products.
x
11 The graduates will be able to recognize plants with medical, economic and toxic potential.
x
12 The graduates shall know and will be able to take part in quality assurance. x
13 The graduates shall know and successfully take part in the production and development of the biotechnological and radiopharmaceutical products.
x
14 The graduates will know the drug licensing policies, data protection, and evaluates the relationship between patent issues.
x
15 The graduates shall comprehend the issues of drug recognition, ensuring of drug quality, drug control and standardization.
x
16 The graduates shall know the therapeutic effects of the effective substances of drug and solves problems related to drug such as pharmacokinetic properties and stability
x
17 The graduates will be able to advice on intelligent and safe use of drugs, and they will assist in pharmacovigilance applications.
x
18
The graduates will know the major determinants of the extent and kinetics of drug and drug product instability (e.g., temperature, humidity, light, pH, oxygen, free radicals) and the common types of reactions (and their mechanisms) which influence drug and drug product stability (e.g., hydrolysis, oxidation, cyclization, racemization)
x
19 The graduates will be able to set-up and perform an (scientific) experiment, collect data, evaluate the results and to resolve the problems in the laboratory.
x
20 The graduates will be able to follow and acquire scientific and technological knowledge and improvements
x
21 The graduates will be able to control the physical, chemical, biological, toxicological and pharmaceutical characteristics of nanoformulations.
x
22 The graduates will have knowledge about the mechanism of actions of drugs, their side effects and the benefits of using controlled release and/or nanoformulations to increase the effects of drugs.
x
23 The graduates will become familiar with pharmaceutical data bases and knows how to use them to determine the state of the art of all pharmaceutical technologies.
x
contribution level: 1 (low) – 5 (high)
ECTS – workload table
Activity Number Time (hour) Total workload Class Hours 9 3 28
Other Applications
Final Examinations (including preparatory year) 1 2 2
Quiz
Term Paper/ Project
Portfolio Study
Reports
Learning Diary
Thesis/ Project 1 18 18
Seminar
Other
Working Hours out of Class 15 6 90
Assignments
Presentation 1 1 1
Mid-term Examinations (including time for preparation)
Project
Clinical Practice
Laboratory
Field Work
Total Workload 139
Total Workload / 25 5.56
ECTS Credit of Course 6
Optional lectures (during the third and fourth year)
Introduction to Polymer Chemistry (EF3302)
ECTS: 2 2 h/w theory Period: to be announced
Coordinator: Binnur Temel, PhD
Course objective:
Providing a basic understanding of the chemistry of organic, inorganic, and biopolymers,
with an emphasis on synthesis, mechanism, and reaction kinetics. Modern methods of
polymer characterization will be also discussed.
Course contents:
History of polymers, fundamental concepts in polymer science (classification, molecular
weight, glass transition temperature and melting point etc.), polymerization techniques
and mechanisms, thermal and mechanical properties of polymers, natural and synthetic
polymers and applications of polymers in pharmacy.
Learning outcomes:
Students will recognize the importance of organic chemistry on the daily life and
industry and will learn the basic topics of polymer chemistry.
Form of tuition:
Lectures, tutorials and self-study
Course material:
PowerPoint presentations, text book and internet
Literature:
Polymer Synthesis, P.Remp, Merril
Principles of Polymerization, 4th Edition by George Odian
Polymer Chemistry: An Introduction, 3rd Edition by Malcolm P. Stevens
Principles of Polymer Chemistry by Paul J. Flory
Textbook of Polymer Chemistry by Fred W. Billmeyer
Entry requirements:
None
Course contents per week
Course contents – lectures
Week Contents
1 History of Macromolecular Science
2 Concept of Macromolecules
3 Basic Concepts in Polymer Science
4 Chemical Bonding in Polymers
5 Stereochemistry of Polymers
6 Monomer Structure and Polymerizability
7 Polymerization Methods
8 Polymerization Methods
9 Polymerization Methods
10 Concept of Crystallization in Polymers
11 Polymer Characterization
12 Polymer Characterization
13 Reactions on Polymers
14 Natural Polymers
15 Natural Polymers
Course contents – practical courses
Week Contents
1
2
3
4
Assessment and evaluation system
Mid-term study Number Contribution (%)
Mid-term exam 1 100
Quiz - -
Project - -
Reports - -
Seminar - -
Assignments - -
Presentation - -
Laboratory - -
Field work - -
Total 1 100
Contribution of mid-term
studies to pass mark
(%)
- 40
Contribution of final
exam to pass mark (%)
- 60
Total 100
Relationship between the learning outcomes of the course and the programme
outcomes
No Programme outcomes 1 2 3 4 5
1
The graduates shall know the historical developments, the
importance and characteristics of pharmacies in the world and
Turkey. The graduates shall know the national and international
healthcare related organizations.
2 The graduates shall know the ethical and legal principles in the field
of pharmacy and pharmaceutical sciences.
3
The graduates will be able to communicate health-related subjects
and drug-related information to patients, health professionals and
other parties.
4 The graduates will be able to follow, understand and apply the
latest developments in pharmacies and pharmaceutical sciences.
5 The graduates will have the administrative and technical
proficiencies around the responsibility given by law.
6 The graduates will be able to organize pharmacies and other
pharmaceutical applications according to the rules.
7 The graduates will understand and successfully take part in every
stage from design of pharmaceutical products to their marketing.
8 The graduates will be able to plan and perform all issues within the
pharmaceutical services in the hospital.
9
The graduates will have knowledge about the obtainment,
production and product technologies and production, obtainment of
the natural and chemical pharmaceutical raw materials.
10
The graduates will be able to inform patients, their relatives and
(patient) organizations in issues according to the safety and quality
of natural products.
11 The graduates will be able to recognize plants with medical,
economic and toxic potential.
12 The graduates shall know and will be able to take part in quality
assurance.
13
The graduates shall know and successfully take part in the
production and development of the biotechnological and
radiopharmaceutical products.
14 The graduates will know the drug licensing policies, data protection,
and evaluates the relationship between patent issues.
15 The graduates shall comprehend the issues of drug recognition,
ensuring of drug quality, drug control and standardization.
16
The graduates shall know the therapeutic effects of the effective
substances of drug and solves problems related to drug such as
pharmacokinetic properties and stability
17 The graduates will be able to advice on intelligent and safe use of
drugs, and they will assist in pharmacovigilance applications.
18
The graduates will know the major determinants of the extent and
kinetics of drug and drug product instability (e.g., temperature,
humidity, light, pH, oxygen, free radicals) and the common types of
reactions (and their mechanisms) which influence drug and drug
product stability (e.g., hydrolysis, oxidation, cyclization,
racemization)
19
The graduates will be able to set-up and perform an (scientific)
experiment, collect data, evaluate the results and to resolve the
problems in the laboratory.
20 The graduates will be able to follow and acquire scientific and
technological knowledge and improvements
21 The graduates will be able to control the physical, chemical,
biological, toxicological and pharmaceutical characteristics of
nanoformulations.
22
The graduates will have knowledge about the mechanism of actions
of drugs, their side effects and the benefits of using controlled
release and/or nanoformulations to increase the effects of drugs.
23
The graduates will become familiar with pharmaceutical data bases
and knows how to use them to determine the state of the art of all
pharmaceutical technologies.
contribution level: 1 (low) – 5 (high)
ECTS – workload table
Activity Number Time (hour) Total workload
Class Hours 15 2 30
Other Applications 0 0 0
Mid-term Examinations (including time for
preparation) 1 5 5
Quiz 0 0 0
Term Paper/ Project 0 0 0
Portfolio Study 0 0 0
Reports 0 0 0
Learning Diary 0 0 0
Thesis/ Project 0 0 0
Seminar 0 0 0
Other 0 0 0
Working Hours out of Class 8 2 16
Assignments 0 0 0
Presentation 0 0 0
Final Examinations (including preparatory
year) 1 10 10
Project 0 0 0
Clinical Practice 0 0 0
Laboratory 0 0 0
Field Work 0 0 0
Total Workload 61
Total Workload / 25 2.44
ECTS Credit of Course 2
Synthetic Organic Chemistry (EF3303)
ECTS: 3 3 h/w theory Period: to be announced
Coordinator: Binnur Temel, PhD
Course objective:
Providing a basic understanding of structure, reactivity and synthesis of biologically
important molecules. Particular emphasis is placed on carbohydrates, amino acids,
peptides, proteins, lipids, and nucleic acids. An introduction to the organic chemistry of
metabolism is given. Also, pericyclic reactions will be discussed.
Course contents:
Basic synthesis methods for a compound which has pharmaceutical importance,
functional group transformation and stereochemical synthesis strategies, planning the
synthesis of targeting molecule, total synthesis, retrosynthetic analysis and strategies,
several synthesis examples.
Learning outcomes:
Students will have knowledge about:
- base of synthetic organic chemistry reactions
- structure-reactivity principles in a variety of chemical structures
Students will be able to:
- to devise synthetic strategies to complex molecule construction
- develop fundamental critical thinking skills, including pattern recognition and
analogous reasoning
Form of tuition:
Lectures, tutorials and self-study
Course material:
PowerPoint presentations, text book and internet
Literature:
Advanced Organic Chemistry, Part B: Reactions and Synthesis, 5th edition (2008) by
Francis A. Carey and Richard J. Sundberg
Advanced Organic Chemistry, M. Smith and J. March
Comprehensive Organic Transformations , R. C. Larock
Entry requirements:
None
Course contents per week
Course contents – lectures
Week Contents
1 What is Organic Synthesis?
2 What is Organic Synthesis?
3 What is Organic Synthesis?
4 Synthesis of alkynes by alkylations
5 Synthesis of alkynes by Pd-catalyzed
reactions
6 Synthesis of alkenes and substituted
arenes
7 Synthesis of alkenes and substituted
arenes
8 Functional group manipulation
9 Functional group manipulation
10 Carbonyl chemistry
11 Carbonyl chemistry
12 Carbonyl chemistry
13 Pericyclic reactions
14 Pericyclic reactions
15 Pericyclic reactions
Course contents – practical courses
Week Contents
1
2
3
4
Assessment and evaluation system
Mid-term study Number Contribution (%)
Mid-term exam 1 90
Quiz - -
Project - -
Reports - -
Seminar - -
Assignments 1 10
Presentation - -
Laboratory - -
Field work - -
Total 2 100
Contribution of mid-term
studies to pass mark
(%)
- 40
Contribution of final
exam to pass mark (%)
- 60
Total 100
Relationship between the learning outcomes of the course and the programme
outcomes
No Programme outcomes 1 2 3 4 5
1
The graduates shall know the historical developments, the
importance and characteristics of pharmacies in the world and
Turkey. The graduates shall know the national and international
healthcare related organizations.
2 The graduates shall know the ethical and legal principles in the field
of pharmacy and pharmaceutical sciences.
3
The graduates will be able to communicate health-related subjects
and drug-related information to patients, health professionals and
other parties.
4 The graduates will be able to follow, understand and apply the
latest developments in pharmacies and pharmaceutical sciences.
5 The graduates will have the administrative and technical
proficiencies around the responsibility given by law.
6 The graduates will be able to organize pharmacies and other
pharmaceutical applications according to the rules.
7 The graduates will understand and successfully take part in every
stage from design of pharmaceutical products to their marketing.
8 The graduates will be able to plan and perform all issues within the
pharmaceutical services in the hospital.
9
The graduates will have knowledge about the obtainment,
production and product technologies and production, obtainment of
the natural and chemical pharmaceutical raw materials.
10
The graduates will be able to inform patients, their relatives and
(patient) organizations in issues according to the safety and quality
of natural products.
11 The graduates will be able to recognize plants with medical,
economic and toxic potential.
12 The graduates shall know and will be able to take part in quality
assurance.
13
The graduates shall know and successfully take part in the
production and development of the biotechnological and
radiopharmaceutical products.
14 The graduates will know the drug licensing policies, data protection,
and evaluates the relationship between patent issues.
15 The graduates shall comprehend the issues of drug recognition,
ensuring of drug quality, drug control and standardization.
16
The graduates shall know the therapeutic effects of the effective
substances of drug and solves problems related to drug such as
pharmacokinetic properties and stability
17 The graduates will be able to advice on intelligent and safe use of
drugs, and they will assist in pharmacovigilance applications.
18
The graduates will know the major determinants of the extent and
kinetics of drug and drug product instability (e.g., temperature,
humidity, light, pH, oxygen, free radicals) and the common types of
reactions (and their mechanisms) which influence drug and drug
product stability (e.g., hydrolysis, oxidation, cyclization,
racemization)
19
The graduates will be able to set-up and perform an (scientific)
experiment, collect data, evaluate the results and to resolve the
problems in the laboratory.
20 The graduates will be able to follow and acquire scientific and
technological knowledge and improvements
21 The graduates will be able to control the physical, chemical,
biological, toxicological and pharmaceutical characteristics of
nanoformulations.
22
The graduates will have knowledge about the mechanism of actions
of drugs, their side effects and the benefits of using controlled
release and/or nanoformulations to increase the effects of drugs.
23
The graduates will become familiar with pharmaceutical data bases
and knows how to use them to determine the state of the art of all
pharmaceutical technologies.
contribution level: 1 (low) – 5 (high)
ECTS – workload table
Activity Number Time (hour) Total workload
Class Hours 15 3 45
Other Applications 0 0 0
Mid-term Examinations (including time for
preparation) 1 5 5
Quiz 0 0 0
Term Paper/ Project 0 0 0
Portfolio Study 0 0 0
Reports 0 0 0
Learning Diary 0 0 0
Thesis/ Project 0 0 0
Seminar 0 0 0
Other 0 0 0
Working Hours out of Class 8 3 24
Assignments 1 3 3
Presentation 0 0 0
Final Examinations (including preparatory
year) 1 10 10
Project 0 0 0
Clinical Practice 0 0 0
Laboratory 0 0 0
Field Work 0 0 0
Total Workload 87
Total Workload / 25 3.48
ECTS Credit of Course 3
Synthesis and Preparation of New Drug Delivery Systems (EF3305)
ECTS: 2 2 h/w theory Period: to be announced
Coordinators: Binnur Temel, PhD & Fatemeh Bahadori, PhD
Course objective:
Students will understand the differences between Controlled Release Drug Delivery
Systems and classic drugs and will become familiar with nano-scaled drugs
Course contents:
Fundamental concepts in controlled drug delivery systems, function and preparation of
drug delivery systems, colloidal drug delivery systems, micro and nanoparticle systems,
drug targeting, design, synthesis and preparation of new carrier systems, use of
nanotechnology in drug delivery systems, protein carrier and bioadhesive systems.
Learning outcomes:
Students will have knowledge about:
- types of new drug delivery systems
- their preparation techniques
- recent developments
Form of tuition:
Lectures, tutorials and self-study
Course material:
Powerpoint presentations
Literature:
Drug Delivery Systems, J.R.Juliano, Oxford University Press
Controlled Drug Delivery, J.R.Robinson and Vincent H.L. Lee, Drugs and Pharm. Sci.
Series, Vol. 29, Marcel Dekker Inc.
Novel Drug Delivery Systems, Yie W. Chien, Drugs and Pharm. Sci. Series, Vol.14,
Marcel Dekker Inc.N.Y.
Sustained and Controlled Release Drug Delivery Systems, Joseph R. Robinson, Drugs &
Pharm. Sci. Series, Vol. 6 Marcel Inc.,N.Y.
Polymers in Controlled Drug Ddelivery, Lisbeth, llum & Stanley S. Davis.
Entry requirements:
None
Course contents per week
Course contents – lectures
Week Contents
1 Theory of controlled release drug delivery
systems
2 Theory of controlled release drug delivery
systems
3 Microencapsulation
4 Microencapsulation
5 Transdermal drug delivery systems
6 Implants and Inserts
7 Targetted drug delivery systems
8 Targetted drug delivery systems
9 Liposomes
10 Advanced concepts in the design,
development and production of sustained
release products
11 Advanced concepts in the design,
development and production of sustained
release products
12 Advanced concepts in the design,
development and production of sustained
release products
13 Recent innovations in conventional dosage
form like tablets, capsules, sterile dosage
forms, pellets, Mucoadhesive system,
GRDDS etc.
14 Introduction of formulation of protein and
peptides
15 Introduction of formulation of protein and
peptides
Course contents – practical courses
Week Contents
1
2
3
4
Assessment and evaluation system
Mid-term study Number Contribution (%)
Mid-term exam 1 80
Quiz - -
Project - -
Reports - -
Seminar - -
Assignments 2 10
Presentation - -
Laboratory - -
Field work - -
Total 1 100
Contribution of mid-term
studies to pass mark
(%)
- 40
Contribution of final
exam to pass mark (%)
- 60
Total 100
Relationship between the learning outcomes of the course and the programme
outcomes
No Programme outcomes 1 2 3 4 5
1
The graduates shall know the historical developments, the
importance and characteristics of pharmacies in the world and
Turkey. The graduates shall know the national and international
healthcare related organizations.
2 The graduates shall know the ethical and legal principles in the field
of pharmacy and pharmaceutical sciences.
3
The graduates will be able to communicate health-related subjects
and drug-related information to patients, health professionals and
other parties.
4 The graduates will be able to follow, understand and apply the
latest developments in pharmacies and pharmaceutical sciences.
5 The graduates will have the administrative and technical
proficiencies around the responsibility given by law.
6 The graduates will be able to organize pharmacies and other
pharmaceutical applications according to the rules.
7 The graduates will understand and successfully take part in every
stage from design of pharmaceutical products to their marketing.
8 The graduates will be able to plan and perform all issues within the
pharmaceutical services in the hospital.
9
The graduates will have knowledge about the obtainment,
production and product technologies and production, obtainment of
the natural and chemical pharmaceutical raw materials.
10
The graduates will be able to inform patients, their relatives and
(patient) organizations in issues according to the safety and quality
of natural products.
11 The graduates will be able to recognize plants with medical,
economic and toxic potential.
12 The graduates shall know and will be able to take part in quality
assurance.
13
The graduates shall know and successfully take part in the
production and development of the biotechnological and
radiopharmaceutical products.
14 The graduates will know the drug licensing policies, data protection,
and evaluates the relationship between patent issues.
15 The graduates shall comprehend the issues of drug recognition,
ensuring of drug quality, drug control and standardization.
16
The graduates shall know the therapeutic effects of the effective
substances of drug and solves problems related to drug such as
pharmacokinetic properties and stability
17 The graduates will be able to advice on intelligent and safe use of
drugs, and they will assist in pharmacovigilance applications.
18
The graduates will know the major determinants of the extent and
kinetics of drug and drug product instability (e.g., temperature,
humidity, light, pH, oxygen, free radicals) and the common types of
reactions (and their mechanisms) which influence drug and drug
product stability (e.g., hydrolysis, oxidation, cyclization,
racemization)
19
The graduates will be able to set-up and perform an (scientific)
experiment, collect data, evaluate the results and to resolve the
problems in the laboratory.
20 The graduates will be able to follow and acquire scientific and
technological knowledge and improvements
21 The graduates will be able to control the physical, chemical,
biological, toxicological and pharmaceutical characteristics of
nanoformulations.
22
The graduates will have knowledge about the mechanism of actions
of drugs, their side effects and the benefits of using controlled
release and/or nanoformulations to increase the effects of drugs.
23
The graduates will become familiar with pharmaceutical data bases
and knows how to use them to determine the state of the art of all
pharmaceutical technologies.
contribution level: 1 (low) – 5 (high)
ECTS – workload table
Activity Number Time (hour) Total workload
Class Hours 15 2 30
Other Applications 0 0 0
Mid-term Examinations (including time for
preparation) 1 5 5
Quiz 0 0 0
Term Paper/ Project 0 0 0
Portfolio Study 0 0 0
Reports 0 0 0
Learning Diary 0 0 0
Thesis/ Project 0 0 0
Seminar 0 0 0
Other 0 0 0
Working Hours out of Class 6 2 12
Assignments 2 2 4
Presentation 0 0 0
Final Examinations (including preparatory
year) 1 10 10
Project 0 0 0
Clinical Practice 0 0 0
Laboratory 0 0 0
Field Work 0 0 0
Total Workload 61
Total Workload / 25 2.44
ECTS Credit of Course 2
Nano Drug Delivery Systems and their Applications (EF4302)
ECTS: 2 2 h/w theory Period to be announced
Coordinator: Fatemeh Bahadori, PhD
Course objective:
The main objective of this course is to introduce the place of Nano Technology in
pharmaceutical applications, the advantages of Nano formulations to classic drugs and
to explain the materials and methods used in preparation of Nano Drug Delivery
Systems
Course contents:
A short review of the use of nano materials in prevention, diagnosis and treatment of
different diseases. Introducing different nano drug delivery systems, including gold nano
particles, carbon nanotubes, polymeric and lipid based materials and the advantages
and disadvantages of use of these materials for specified aims, like treatment of cancer,
rheumatoid arthritis, diabetes and Alzheimer’s disease. Uploading methods used to
upload drugs to different nano drug delivery systems. Explaining materials, methods and
instruments are used in characterization of nano drug delivery systems. Release studies
of nano drugdelivery systems and the pharmacokinetic of nano formulations.
Learning outcomes:
The graduates will gain a new point of view as an alternative for the traditional
pharmaceutical methods. They will learn how to use the possibilities of nano materials
for solving the problms associated with the traditional nano-formulations. They also will
become familiar with different materials such as polymers, cyclodextrines and chitosan
which are popular in production of nano-formulations
Form of tuition:
Lectures, tutorials and self-study
Course material:
Powerpoint presentations
Literature:
Entry requirements:
EF 3258
Course contents per week
Course contents – lectures
Week Contents
1 Introduction to nano scaled materials, pharmaceutical nano-formulations, their
applications and benefits
2 Polymeric drug delivery systems used in
production of nano-formulations.
3 Nano-capsules, nano-spheres and nano-gels
4 Nano-dendrimers
5 lipspmes
6 Niosomes
7 Solid lipid nano particles
8 Nano-emulsions
9 Micelles
10 Nano-crystals
11 Nano-tubes and nano-cages
12 Polymer-protein conjugates
13 Targeted drug delivery to cancer side using nano-formulations
14 Passing through Blood Brain Barrier using nano formulations
15 Are nano formulations safe?
Course contents – practical courses
Week Contents
1
Assessment and evaluation system
Mid-term study Number Contribution (%)
Mid-term exam 1 50
Quiz 2 40
Project - -
Reports - -
Seminar - -
Assignments 2 10
Presentation - -
Laboratory - -
Field work - -
Total 5 100
Contribution of mid-term
studies to pass mark
(%)
- 40
Contribution of final
exam to pass mark (%)
- 60
Total 100
Relationship between the learning outcomes of the course and the programme outcomes
No Programme outcomes 1 2 3 4 5
1 The graduates shall know the historical developments, the importance and characteristics of pharmacies in the world and Turkey. The graduates shall know the national and international healthcare related organizations.
X
2 The graduates shall know the ethical and legal principles in the field of pharmacy and pharmaceutical sciences.
X
3 The graduates will be able to communicate health-related subjects and drug-related information to patients, health professionals and other parties.
X
4 The graduates will be able to follow, understand and apply the latest developments in pharmacies and pharmaceutical sciences.
X
5 The graduates will have the administrative and technical proficiencies around the responsibility given by law.
X
6 The graduates will be able to organize pharmacies and other pharmaceutical applications according to the rules.
X
7 The graduates will understand and successfully take part in every stage from design of pharmaceutical products to their marketing.
X
8 The graduates will be able to plan and perform all issues within the pharmaceutical services in the hospital.
X
9 The graduates will have knowledge about the obtainment, production and product technologies and production, obtainment of the natural and chemical pharmaceutical raw materials.
X
10 The graduates will be able to inform patients, their relatives and (patient) organizations in issues according to the safety and quality of natural products.
X
11 The graduates will be able to recognize plants with medical, economic and toxic potential.
X
12 The graduates shall know and will be able to take part in quality assurance. X
13 The graduates shall know and successfully take part in the production and development of the biotechnological and radiopharmaceutical products.
X
14 The graduates will know the drug licensing policies, data protection, and evaluates the relationship between patent issues.
X
15 The graduates shall comprehend the issues of drug recognition, ensuring of drug quality, drug control and standardization.
X
16 The graduates shall know the therapeutic effects of the effective substances of drug and solves problems related to drug such as pharmacokinetic properties and stability
X
17 The graduates will be able to advice on intelligent and safe use of drugs, and they will assist in pharmacovigilance applications.
X
18
The graduates will know the major determinants of the extent and kinetics of drug and drug product instability (e.g., temperature, humidity, light, pH, oxygen, free radicals) and the common types of reactions (and their mechanisms) which influence drug and drug product stability (e.g., hydrolysis, oxidation, cyclization, racemization)
X
19 The graduates will be able to set-up and perform an (scientific) experiment, collect data, evaluate the results and to resolve the problems in the laboratory.
X
20 The graduates will be able to follow and acquire scientific and technological knowledge and improvements
X
21 The graduates will be able to control the physical, chemical, biological, toxicological and pharmaceutical characteristics of nanoformulations.
X
22 The graduates will have knowledge about the mechanism of actions of drugs, their side effects and the benefits of using controlled release and/or nanoformulations to increase the effects of drugs.
X
23 The graduates will become familiar with pharmaceutical data bases and knows how to use them to determine the state of the art of all pharmaceutical technologies.
X
contribution level: 1 (low) – 5 (high)
ECTS – workload table
Activity Number Time (hour) Total workload
Class Hours 15 2 30
Other Applications 0 0 0
Mid-term Examinations (including time for
preparation) 1 5 5
Quiz 2 1 2
Term Paper/ Project 0 0 0
Portfolio Study 0 0 0
Reports 0 0 0
Learning Diary 0 0 0
Thesis/ Project 0 0 0
Seminar 0 0 0
Other 0 0 0
Working Hours out of Class 7 1 7
Assignments 2 2 4
Presentation 0 0 0
Final Examinations (including preparatory
year) 1 5 5
Project 0 0 0
Clinical Practice 0 0 0
Laboratory 0 0 0
Field Work 0 0 0
Total Workload 53
Total Workload / 25 2,12
ECTS Credit of Course 2
The Role of Enzymes in Diseases and Enzymes as targets for drug development (EF4303)
ECTS: 2 2 h/w theory Period: to be announced
Coordinator: Atilla Akdemir, PhD
Course objective: Providing a basic understanding of enzymes in diseases. We will discuss examples of several important enzymes as drug targets for various diseases. Course contents: General introduction to enzymes; structure of enzymes; enzymes in physiology and
pathophysiology; enzyme reaction mechanisms; enzyme inhibition assays; important enzymes for pharmaceutical companies: CA, COX, AChE, BChE, ACE, proteases, reverse transcriptases. Learning outcomes: The students:
will be able to discuss enzymes and their characteristics will be able to discuss enzyme inhibition assays
will be able to discuss the physiological role of several important enzymes: CA, COX,
AChE, BChE, ACE, proteases, reverse transcriptases Form of tuition: Lectures, tutorials and self-study
Course material: Powerpoint presentations, internet Literature: -- Entry requirements:
None
Course contents per week
Course contents – lectures Week Contents
1 introduction to enzymes
2 enzyme characteristics
3 enzyme structures
4 enzyme inhibition assays
5 enzyme inhibition assays
6 carbonic anhydrases
7 carbonic anhydrases
8 acetyl/butyryl cholinesterases
9 acetyl/butyryl cholinesterases
10 cyclooxygenases
11 cyclooxygenases
12 proteases
13 proteases
14 reverse transcriptases
15 reverse transcriptases
Assessment and evaluation system
Mid-term study Number Contribution (%)
Quiz
Project
Reports
Seminar
Assignments
Presentation
Laboratory
Field work
Total
Contribution of mid-term studies to pass mark
40
Contribution of final exam to pass mark
60
Relationship between the learning outcomes of the course and the programme outcomes
No Programme outcomes 1 2 3 4 5
1 The graduates shall know the historical developments, the importance and characteristics of pharmacies in the world and Turkey. The graduates shall know the national and international healthcare related organizations.
x
2 The graduates shall know the ethical and legal principles in the field of pharmacy and pharmaceutical sciences.
x
3 The graduates will be able to communicate health-related subjects and drug-related information to patients, health professionals and other parties.
x
4 The graduates will be able to follow, understand and apply the latest developments in pharmacies and pharmaceutical sciences.
x
5 The graduates will have the administrative and technical proficiencies around the responsibility given by law.
x
6 The graduates will be able to organize pharmacies and other pharmaceutical applications according to the rules.
x
7 The graduates will understand and successfully take part in every stage from design of pharmaceutical products to their marketing.
x
8 The graduates will be able to plan and perform all issues within the pharmaceutical services in the hospital.
x
9 The graduates will have knowledge about the obtainment, production and product technologies and production, obtainment of the natural and chemical pharmaceutical raw materials.
x
10 The graduates will be able to inform patients, their relatives and (patient) organizations in issues according to the safety and quality of natural products.
x
11 The graduates will be able to recognize plants with medical, economic and toxic potential.
x
12 The graduates shall know and will be able to take part in quality assurance. x
13 The graduates shall know and successfully take part in the production and development of the biotechnological and radiopharmaceutical products.
x
14 The graduates will know the drug licensing policies, data protection, and evaluates the relationship between patent issues.
x
15 The graduates shall comprehend the issues of drug recognition, ensuring of drug quality, drug control and standardization.
x
16 The graduates shall know the therapeutic effects of the effective substances of drug and solves problems related to drug such as pharmacokinetic properties and stability
x
17 The graduates will be able to advice on intelligent and safe use of drugs, and they will assist in pharmacovigilance applications.
x
18
The graduates will know the major determinants of the extent and kinetics of drug and drug product instability (e.g., temperature, humidity, light, pH, oxygen, free radicals) and the common types of reactions (and their mechanisms) which influence drug and drug product stability (e.g., hydrolysis, oxidation, cyclization, racemization)
x
19 The graduates will be able to set-up and perform an (scientific) experiment, collect data, evaluate the results and to resolve the problems in the laboratory.
x
20 The graduates will be able to follow and acquire scientific and technological knowledge and improvements
x
21 The graduates will be able to control the physical, chemical, biological, toxicological and pharmaceutical characteristics of nanoformulations.
x
22 The graduates will have knowledge about the mechanism of actions of drugs, their side effects and the benefits of using controlled release and/or nanoformulations to increase the effects of drugs.
x
23 The graduates will become familiar with pharmaceutical data bases and knows how to use them to determine the state of the art of all pharmaceutical technologies.
x
contribution level: 1 (low) – 5 (high)
ECTS – workload table
Activity Number Time (hour) Total workload Class Hours 15 2 30
Other Applications
Final Examinations (including preparatory year) 1 2 2
Quiz 1 2 1
Term Paper/ Project
Portfolio Study
Reports
Learning Diary
Thesis/ Project
Seminar
Other
Working Hours out of Class 15 1.8 27
Assignments
Presentation
Mid-term Examinations (including time for preparation)
Project
Clinical Practice
Laboratory
Field Work
Total Workload 60
Total Workload / 25 2.4
ECTS Credit of Course 2
Expertness lectures (during fifth year)
Development of New Analytical Methods and Validation (EF5321)
ECTS: 5 3 h/w theory; 2 h/w practice Period to be announced
Coordinator: Evrim Tekkeli, PhD
Course objective:
Providing students to be able to analyse different kinds of matrices, develop new
analytical methods and validate.
Course contents:
Quality control of drugs, qualitative and quantitative impurity analysis, determination of
excipients, bioequivalance and bioavailability, basic principles in developing new
methods, validation parameters (selectivity, linearity, accuracy, precision, robustness,
limit of dedection, limit of quantitation), the role of statistics in method validation and
applications, converting the data of analysis to reports.
Learning outcomes:
The students:
• will be able to develop a new analytical methods using chromatographic
techniques
• will be able to validate an analytical method
Form of tuition:
Lectures, tutorials and self-study
Course material:
Powerpoint presentations, videos
Literature:
Instrumental analysis- Skoog; Goodman and Gilman’s The Pharmacological Basis of
Therapeutics; Guidance for Industry, Bioanalytical Method Validation, US Department of
Health and Human Services, Food and Drug Administration; Text on Validation of
Analytical Procedures Q2A, International Conference on Harmonisation of Technical
Requirements for Registration of Pharmaceuticals for Human Use.
Entry requirements:
None
Course contents per week
Course contents – lectures
Week Contents
1 Principles of method development and validation, studies on related ICH Guidelines
2 Principles of method development and validation, studies on related ICH Guidelines
3 Studying on how to choose applicable method
4 Chromatographic separation techniques
5 Suitable dedections for chromatographic process
6 Bioequivalance studies
7 Bioavailability studies
8 Quality control principles of pharmaceutical preparations
9 Interferences in analysis
10 Validation procedures
11 Validation parameters
12 Statistical test related to drug development
13 Data converting to an analyse report
14 Problem based studies about developing a new method for drug analysis
15
Problem based studies about developing a new method for drug analysis
Course contents – practical courses
Week Contents
1 ____
2 ____
3 HPLC study for drug analysis form pharmaceutical preparations
4 HPLC study for drug analysis form pharmaceutical preparations
5 HPLC study for drug analysis form pharmaceutical preparations
6 HPLC study for drug analysis form pharmaceutical preparations
7 HPLC study for drug analysis form pharmaceutical preparations
8 HPLC study for drug analysis form pharmaceutical preparations
9 HPLC study for drug analysis from pharmaceutical preparations
10 HPLC study for drug analysis from biological fluids
11 HPLC study for drug analysis from biological fluids
12 UPLC study for drug analysis from pharmaceutical preparations
13 UPLC study for drug analysis from biological fluids
14 Literature survey for new methods
15 Presentations about developing new methods for drug analysis
Assessment and evaluation system
Mid-term study Number Contribution (%)
Mid-term exam 1 100
Quiz 2 10
Project 1 20
Reports --- ---
Seminar --- ---
Assignments ---
Presentation 1 5
Laboratory 14 ---
Field work --- ---
Total --- ---
Contribution of mid-term studies to pass mark
40
Contribution of final exam to pass mark
60
Relationship between the learning outcomes of the course and the programme outcomes
No Programme outcomes 1 2 3 4 5
1 The graduates shall know the historical developments, the importance and characteristics of pharmacies in the world and Turkey. The graduates shall know the national and international healthcare related organizations.
x
2 The graduates shall know the ethical and legal principles in the field of pharmacy and pharmaceutical sciences.
x
3 The graduates will be able to communicate health-related subjects and drug-related information to patients, health professionals and other parties.
x
4 The graduates will be able to follow, understand and apply the latest developments in pharmacies and pharmaceutical sciences.
x
5 The graduates will have the administrative and technical proficiencies around the responsibility given by law.
x
6 The graduates will be able to organize pharmacies and other pharmaceutical applications according to the rules.
x
7 The graduates will understand and successfully take part in every stage from design of pharmaceutical products to their marketing.
x
8 The graduates will be able to plan and perform all issues within the pharmaceutical services in the hospital.
x
9 The graduates will have knowledge about the obtainment, production and product technologies and production, obtainment of the natural and chemical pharmaceutical raw materials.
x
10 The graduates will be able to inform patients, their relatives and (patient) organizations in issues according to the safety and quality of natural products.
x
11 The graduates will be able to recognize plants with medical, economic and toxic potential.
x
12 The graduates shall know and will be able to take part in quality assurance. x
13 The graduates shall know and successfully take part in the production and development of the biotechnological and radiopharmaceutical products.
x
14 The graduates will know the drug licensing policies, data protection, and evaluates the relationship between patent issues.
x
15 The graduates shall comprehend the issues of drug recognition, ensuring of drug quality, drug control and standardization.
x
16 The graduates shall know the therapeutic effects of the effective substances of drug and solves problems related to drug such as pharmacokinetic properties and stability
x
17 The graduates will be able to advice on intelligent and safe use of drugs, and they will assist in pharmacovigilance applications.
x
18
The graduates will know the major determinants of the extent and kinetics of drug and drug product instability (e.g., temperature, humidity, light, pH, oxygen, free radicals) and the common types of reactions (and their mechanisms) which influence drug and drug product stability (e.g., hydrolysis, oxidation, cyclization, racemization)
x
19 The graduates will be able to set-up and perform an (scientific) experiment, collect data, evaluate the results and to resolve the problems in the laboratory.
x
20 The graduates will be able to follow and acquire scientific and technological knowledge and improvements
x
21 The graduates will be able to control the physical, chemical, biological, toxicological and pharmaceutical characteristics of nanoformulations.
x
22 The graduates will have knowledge about the mechanism of actions of drugs, their side effects and the benefits of using controlled release and/or nanoformulations to increase the effects of drugs.
x
23 The graduates will become familiar with pharmaceutical data bases and knows how to use them to determine the state of the art of all pharmaceutical technologies.
x
contribution level: 1 (low) – 5 (high)
ECTS – workload table
Activity Number Time (hour) Total workload Class Hours 15 3 45
Other Applications
Final Examinations (including preparatory year) 1 8 8
Quiz 2 4 4
Term Paper/ Project
Portfolio Study
Reports 2 3 6
Learning Diary
Thesis/ Project
Seminar
Other
Working Hours out of Class 5 4 20
Assignments
Presentation 1 5 5
Mid-term Examinations (including time for preparation)
1 6 6
Project 1 5 5
Clinical Practice
Laboratory 13 2 26
Field Work
Total Workload 125
Total Workload / 25 5
ECTS Credit of Course 5
Drug Analysis in Biological Fluids and Pharmaceutical Preparations (EF5322)
ECTS: 3 2 h/w theory; 1 h/w practice Period to be announced
Coordinator: Evrim Tekkeli, PhD
Course objective:
Learning the properties of different biological matrices, sample preparation techniques,
the characteristic properties of pharmaceutical preparations.
Course contents:
Basic principles of drug analysis in biological fluids, types of biological matrices,
pharmaceutical preparations and characteristics, sample preparation techniques and
their applications, derivatization and derivatizing agents, analysis with UV and
fluorimetric detections, investigating pharmacokinetics of drugs.
Learning outcomes:
The students:
• will be able to decide how type of an analytical method is suitable for a specific
matrix.
• will be get detailed information about biological fluids
• will be able to conduct a derivatization procedure
• will be able to describe pharmacokinetics and its importance for medicine
Form of tuition:
Lectures, tutorials and self-study
Course material:
Powerpoint presentations, videos
Literature:
Instrumental analysis- Skoog; Goodman and Gilman’s The Pharmacological Basis of
Therapeutics; Guidance for Industry, Bioanalytical Method Validation, US Department of
Health and Human Services, Food and Drug Administration
Entry requirements:
None
Course contents per week
Course contents – lectures
Week Contents
1 Biological matrices, investigating the properties of plasma, serum, urine, cerebrospinal fluid, etc…
2 Biological matrices, investigating the properties of plasma, serum, urine, cerebrospinal fluid, etc…
3 Pharmaceutical formulations and their characteristics
4 Pharmaceutical formulations and their characteristics
5 Pharmaceutical formulations and their characteristics
6 Sample preparation techniques
7 Solid phase extraction and liquid-liquid extraction from biological fluids, protein precipitation
8 Derivatization
9 Derivatization
10 Analysis in biological fluids with examples
11 Analysis in biological fluids with examples
12 Analysis in biological fluids with examples
13 Pharmacokinetics of drugs
14 Pharmacokinetics of drugs
15
Problem based studies about developing a new method for drug analysis in various biological fluids
Course contents – practical courses
Week Contents
1 ____
2 ____
3 Sample preparation techniques
4 Sample preparation techniques
5 Sample preparation techniques
6 Spectrophotometric derivatization
7 Spectrophotometric derivatization
8 Spectrophotometric derivatization
9 Spectrofluorimetric derivatization
10 Spectrofluorimetric derivatization
11 Spectrofluorimetric derivatization
12 Literature survey for new methods
13 Literature survey for new methods
14 Literature survey for new methods
15 Presentations about developing new methods for drug analysis in biological studies
Assessment and evaluation system
Mid-term study Number Contribution (%)
Mid-term exam 1 100
Quiz 2 10
Project 1 20
Reports --- ---
Seminar --- ---
Assignments ---
Presentation 1 5
Laboratory 13 ---
Field work --- ---
Total --- ---
Contribution of mid-term studies to pass mark
40
Contribution of final exam to pass mark
60
Relationship between the learning outcomes of the course and the programme outcomes
No Programme outcomes 1 2 3 4 5
1 The graduates shall know the historical developments, the importance and characteristics of pharmacies in the world and Turkey. The graduates shall know the national and international healthcare related organizations.
x
2 The graduates shall know the ethical and legal principles in the field of pharmacy and pharmaceutical sciences.
x
3 The graduates will be able to communicate health-related subjects and drug-related information to patients, health professionals and other parties.
x
4 The graduates will be able to follow, understand and apply the latest developments in pharmacies and pharmaceutical sciences.
x
5 The graduates will have the administrative and technical proficiencies around the responsibility given by law.
x
6 The graduates will be able to organize pharmacies and other pharmaceutical applications according to the rules.
x
7 The graduates will understand and successfully take part in every stage from design of pharmaceutical products to their marketing.
x
8 The graduates will be able to plan and perform all issues within the pharmaceutical services in the hospital.
x
9 The graduates will have knowledge about the obtainment, production and product technologies and production, obtainment of the natural and chemical pharmaceutical raw materials.
x
10 The graduates will be able to inform patients, their relatives and (patient) organizations in issues according to the safety and quality of natural products.
x
11 The graduates will be able to recognize plants with medical, economic and toxic potential.
x
12 The graduates shall know and will be able to take part in quality assurance. x
13 The graduates shall know and successfully take part in the production and development of the biotechnological and radiopharmaceutical products.
x
14 The graduates will know the drug licensing policies, data protection, and evaluates the relationship between patent issues.
x
15 The graduates shall comprehend the issues of drug recognition, ensuring of drug quality, drug control and standardization.
x
16 The graduates shall know the therapeutic effects of the effective substances of drug and solves problems related to drug such as pharmacokinetic properties and stability
x
17 The graduates will be able to advice on intelligent and safe use of drugs, and they will assist in pharmacovigilance applications.
x
18
The graduates will know the major determinants of the extent and kinetics of drug and drug product instability (e.g., temperature, humidity, light, pH, oxygen, free radicals) and the common types of reactions (and their mechanisms) which influence drug and drug product stability (e.g., hydrolysis, oxidation, cyclization, racemization)
x
19 The graduates will be able to set-up and perform an (scientific) experiment, collect data, evaluate the results and to resolve the problems in the laboratory.
x
20 The graduates will be able to follow and acquire scientific and technological knowledge and improvements
x
21 The graduates will be able to control the physical, chemical, biological, toxicological and pharmaceutical characteristics of nanoformulations.
x
22 The graduates will have knowledge about the mechanism of actions of drugs, their side effects and the benefits of using controlled release and/or nanoformulations to increase the effects of drugs.
x
23 The graduates will become familiar with pharmaceutical data bases and knows how to use them to determine the state of the art of all pharmaceutical technologies.
x
contribution level: 1 (low) – 5 (high)
ECTS – workload table
Activity Number Time (hour) Total workload Class Hours 15 2 30
Other Applications
Final Examinations (including preparatory year) 1 8 8
Quiz 2 4 8
Term Paper/ Project
Portfolio Study
Reports
Learning Diary
Thesis/ Project 1 5 5
Seminar
Other
Working Hours out of Class
Assignments
Presentation 1 3 3
Mid-term Examinations (including time for preparation)
1 8 8
Project
Clinical Practice
Laboratory 13 1 13
Field Work
Total Workload 75
Total Workload / 25 3
ECTS Credit of Course 3
Computer-aided drug discovery I (EF5324)
ECTS: 3 3 h/w theory Period: to be announced
Coordinator: Atilla Akdemir, PhD
Course objective: We will discuss ways in which ligands can bind selectively and with affinity to their target proteins. In addition, in silico screening procedures will be discussed. Course contents: Ligand binding interactions of several important drugs; development and validation of successful in silico screening procedures and their applications.
Learning outcomes: The students:
will be able to discuss how 3D structures of proteins can be obtained, what information can be extracted from them, and how they can be used in the design of new ligands
will be able to discuss structure-based and ligand-based design procedures will be able to discuss molecular dynamics simulations and what information can be
obtained from them
Form of tuition: Lectures, tutorials and self-study Course material:
Powerpoint presentations, internet Literature: -- Entry requirements: None
Course contents per week
Course contents – lectures Week Contents
1 3D structures of proteins and ligands by NMR and X-ray
2 Protein-ligand interactions
3 Protein-ligand interactions
4 Force fields and calculation of interaction energies
5 Sequence alignments and homology modelling
6 Pharmacophore models and ligand conformational alignments
7 Docking studies
8 Virtual screenings
9 Fragment-based screenings (NMR and in silico)
10 Scaffold hopping
11 De novo ligand generation
12 QSAR
13 3D-QSAR
14 Molecular dynamics
15 Molecular dynamics
Assessment and evaluation system
Mid-term study Number Contribution (%)
Quiz
Project
Reports
Seminar
Assignments
Presentation
Laboratory
Field work
Total
Contribution of mid-term studies to pass mark
40
Contribution of final exam to pass mark
60
Relationship between the learning outcomes of the course and the programme outcomes
No Programme outcomes 1 2 3 4 5
1 The graduates shall know the historical developments, the importance and characteristics of pharmacies in the world and Turkey. The graduates shall know the national and international healthcare related organizations.
x
2 The graduates shall know the ethical and legal principles in the field of pharmacy and pharmaceutical sciences.
x
3 The graduates will be able to communicate health-related subjects and drug-related information to patients, health professionals and other parties.
x
4 The graduates will be able to follow, understand and apply the latest developments in pharmacies and pharmaceutical sciences.
x
5 The graduates will have the administrative and technical proficiencies around the responsibility given by law.
x
6 The graduates will be able to organize pharmacies and other pharmaceutical applications according to the rules.
x
7 The graduates will understand and successfully take part in every stage from design of pharmaceutical products to their marketing.
x
8 The graduates will be able to plan and perform all issues within the pharmaceutical services in the hospital.
x
9 The graduates will have knowledge about the obtainment, production and product technologies and production, obtainment of the natural and chemical pharmaceutical raw materials.
x
10 The graduates will be able to inform patients, their relatives and (patient) organizations in issues according to the safety and quality of natural products.
x
11 The graduates will be able to recognize plants with medical, economic and toxic potential.
x
12 The graduates shall know and will be able to take part in quality assurance. x
13 The graduates shall know and successfully take part in the production and development of the biotechnological and radiopharmaceutical products.
x
14 The graduates will know the drug licensing policies, data protection, and evaluates the relationship between patent issues.
x
15 The graduates shall comprehend the issues of drug recognition, ensuring of drug quality, drug control and standardization.
x
16 The graduates shall know the therapeutic effects of the effective substances of drug and solves problems related to drug such as pharmacokinetic properties and stability
x
17 The graduates will be able to advice on intelligent and safe use of drugs, and they will assist in pharmacovigilance applications.
x
18
The graduates will know the major determinants of the extent and kinetics of drug and drug product instability (e.g., temperature, humidity, light, pH, oxygen, free radicals) and the common types of reactions (and their mechanisms) which influence drug and drug product stability (e.g., hydrolysis, oxidation, cyclization, racemization)
x
19 The graduates will be able to set-up and perform an (scientific) experiment, collect data, evaluate the results and to resolve the problems in the laboratory.
x
20 The graduates will be able to follow and acquire scientific and technological knowledge and improvements
x
21 The graduates will be able to control the physical, chemical, biological, toxicological and pharmaceutical characteristics of nanoformulations.
x
22 The graduates will have knowledge about the mechanism of actions of drugs, their side effects and the benefits of using controlled release and/or nanoformulations to increase the effects of drugs.
x
23 The graduates will become familiar with pharmaceutical data bases and knows how to use them to determine the state of the art of all pharmaceutical technologies.
x
contribution level: 1 (low) – 5 (high)
ECTS – workload table
Activity Number Time (hour) Total workload Class Hours
Other Applications
Final Examinations (including preparatory year)
Quiz
Term Paper/ Project
Portfolio Study
Reports
Learning Diary
Thesis/ Project
Seminar
Other
Working Hours out of Class
Assignments
Presentation
Mid-term Examinations (including time for preparation)
Project
Clinical Practice
Laboratory
Field Work
Total Workload
Total Workload / 25
ECTS Credit of Course
Computer-aided drug discovery II (EF5325)
ECTS: 5 3 h/w theory; 2 h/w practice Period: to be announced
Coordinator: Atilla Akdemir, PhD
Course objective: We will discuss ways in which ligands can bind selectively and with affinity to their target proteins. In addition, in silico screening procedures will be discussed. Course contents: Ligand binding interactions of several important drugs; development and validation of successful in silico screening procedures and their applications. This course will include a project and a
presentation. Learning outcomes: xxxxxxxx Form of tuition: Lectures, tutorials and self-study. Students will do a project and present their results.
Course material: Powerpoint presentations, internet Literature: --
Entry requirements: None
Course contents per week
Course contents – lectures Week Contents
1 3D structures of proteins and ligands by NMR and X-ray
2 Protein-ligand interactions
3 Protein-ligand interactions
4 Force fields and calculation of interaction energies
5 Sequence alignments and homology modelling
6 Pharmacophore models and ligand conformational alignments
7 Docking studies
8 Virtual screenings
9 Fragment-based screenings (NMR and in silico)
10 Scaffold hopping
11 De novo ligand generation
12 QSAR
13 3D-QSAR
14 Molecular dynamics
15 Molecular dynamics
Assessment and evaluation system
Mid-term study Number Contribution (%)
Quiz
Project
Reports
Seminar
Assignments
Presentation
Laboratory
Field work
Total
Contribution of mid-term studies to pass mark
40
Contribution of final exam to pass mark
60
Relationship between the learning outcomes of the course and the programme outcomes
No Programme outcomes 1 2 3 4 5
1 The graduates shall know the historical developments, the importance and characteristics of pharmacies in the world and Turkey. The graduates shall know the national and international healthcare related organizations.
x
2 The graduates shall know the ethical and legal principles in the field of pharmacy and pharmaceutical sciences.
x
3 The graduates will be able to communicate health-related subjects and drug-related information to patients, health professionals and other parties.
x
4 The graduates will be able to follow, understand and apply the latest developments in pharmacies and pharmaceutical sciences.
x
5 The graduates will have the administrative and technical proficiencies around the responsibility given by law.
x
6 The graduates will be able to organize pharmacies and other pharmaceutical applications according to the rules.
x
7 The graduates will understand and successfully take part in every stage from design of pharmaceutical products to their marketing.
x
8 The graduates will be able to plan and perform all issues within the pharmaceutical services in the hospital.
x
9 The graduates will have knowledge about the obtainment, production and product technologies and production, obtainment of the natural and chemical pharmaceutical raw materials.
x
10 The graduates will be able to inform patients, their relatives and (patient) organizations in issues according to the safety and quality of natural products.
x
11 The graduates will be able to recognize plants with medical, economic and toxic potential.
x
12 The graduates shall know and will be able to take part in quality assurance. x
13 The graduates shall know and successfully take part in the production and development of the biotechnological and radiopharmaceutical products.
x
14 The graduates will know the drug licensing policies, data protection, and evaluates the relationship between patent issues.
x
15 The graduates shall comprehend the issues of drug recognition, ensuring of drug quality, drug control and standardization.
x
16 The graduates shall know the therapeutic effects of the effective substances of drug and solves problems related to drug such as pharmacokinetic properties and stability
x
17 The graduates will be able to advice on intelligent and safe use of drugs, and they will assist in pharmacovigilance applications.
x
18
The graduates will know the major determinants of the extent and kinetics of drug and drug product instability (e.g., temperature, humidity, light, pH, oxygen, free radicals) and the common types of reactions (and their mechanisms) which influence drug and drug product stability (e.g., hydrolysis, oxidation, cyclization, racemization)
x
19 The graduates will be able to set-up and perform an (scientific) experiment, collect data, evaluate the results and to resolve the problems in the laboratory.
x
20 The graduates will be able to follow and acquire scientific and technological knowledge and improvements
x
21 The graduates will be able to control the physical, chemical, biological, toxicological and pharmaceutical characteristics of nanoformulations.
x
22 The graduates will have knowledge about the mechanism of actions of drugs, their side effects and the benefits of using controlled release and/or nanoformulations to increase the effects of drugs.
x
23 The graduates will become familiar with pharmaceutical data bases and knows how to use them to determine the state of the art of all pharmaceutical technologies.
x
contribution level: 1 (low) – 5 (high)
ECTS – workload table
Activity Number Time (hour) Total workload Class Hours
Other Applications
Final Examinations (including preparatory year)
Quiz
Term Paper/ Project
Portfolio Study
Reports
Learning Diary
Thesis/ Project
Seminar
Other
Working Hours out of Class
Assignments
Presentation
Mid-term Examinations (including time for preparation)
Project
Clinical Practice
Laboratory
Field Work
Total Workload
Total Workload / 25
ECTS Credit of Course
Molecular Pharmacology and Drug Discovery (EF5327)
ECTS: 5 3 h/w theory; 2 h/w practice Period: to be announced
Coordinator: Atilla Akdemir, PhD
Course objective: Providing working knowledge of molecular pharmacology and related techniques that are frequently used in drug discovery and development procedures. Course contents: This course will discuss commonly used (molecular) pharmacology based research techniques in drug design and development such as: mutagenesis studies, chimeric proteins, ligand-protein
interactions, binding assays, functional assays, enzyme inhibition assays, cell culture, protein-ligand cocrystallization studies, high-throughput screenings. Learning outcomes: The students:
will be able to discuss the role of frequently used (molecular) pharmacology techniques in drug discovery and development
will be able to learn and discuss new research techniques from the literature
Form of tuition: Lectures, tutorials, literature research and self-study Course material:
Powerpoint presentations, internet Literature: -- Entry requirements: None
Course contents per week
Course contents – lectures Week Contents
1 introduction to molecular pharmacology
2 mutagenesis studies
3 chimeric proteins
4 ligand-protein interactions
5 binding assays
6 binding assays
7 functional assays
8 functional assays
9 functional assays
10 enzyme inhibition assays
11 enzyme inhibition assays
12 cell culture
13 cell culture
14 protein-ligand cocrystallization
15 protein-ligand cocrystallization
Assessment and evaluation system
Mid-term study Number Contribution (%)
Quiz
Project
Reports
Seminar
Assignments
Presentation 1 40
Laboratory
Field work
Total
Contribution of mid-term studies to pass mark
40
Contribution of final exam to pass mark
60
Relationship between the learning outcomes of the course and the programme outcomes
No Programme outcomes 1 2 3 4 5
1 The graduates shall know the historical developments, the importance and characteristics of pharmacies in the world and Turkey. The graduates shall know the national and international healthcare related organizations.
x
2 The graduates shall know the ethical and legal principles in the field of pharmacy and pharmaceutical sciences.
x
3 The graduates will be able to communicate health-related subjects and drug-related information to patients, health professionals and other parties.
x
4 The graduates will be able to follow, understand and apply the latest developments in pharmacies and pharmaceutical sciences.
x
5 The graduates will have the administrative and technical proficiencies around the responsibility given by law.
x
6 The graduates will be able to organize pharmacies and other pharmaceutical applications according to the rules.
x
7 The graduates will understand and successfully take part in every stage from design of pharmaceutical products to their marketing.
x
8 The graduates will be able to plan and perform all issues within the pharmaceutical services in the hospital.
x
9 The graduates will have knowledge about the obtainment, production and product technologies and production, obtainment of the natural and chemical pharmaceutical raw materials.
x
10 The graduates will be able to inform patients, their relatives and (patient) organizations in issues according to the safety and quality of natural products.
x
11 The graduates will be able to recognize plants with medical, economic and toxic potential.
x
12 The graduates shall know and will be able to take part in quality assurance. x
13 The graduates shall know and successfully take part in the production and development of the biotechnological and radiopharmaceutical products.
x
14 The graduates will know the drug licensing policies, data protection, and evaluates the relationship between patent issues.
x
15 The graduates shall comprehend the issues of drug recognition, ensuring of drug quality, drug control and standardization.
x
16 The graduates shall know the therapeutic effects of the effective substances of drug and solves problems related to drug such as pharmacokinetic properties and stability
x
17 The graduates will be able to advice on intelligent and safe use of drugs, and they will assist in pharmacovigilance applications.
x
18
The graduates will know the major determinants of the extent and kinetics of drug and drug product instability (e.g., temperature, humidity, light, pH, oxygen, free radicals) and the common types of reactions (and their mechanisms) which influence drug and drug product stability (e.g., hydrolysis, oxidation, cyclization, racemization)
x
19 The graduates will be able to set-up and perform an (scientific) experiment, collect data, evaluate the results and to resolve the problems in the laboratory.
x
20 The graduates will be able to follow and acquire scientific and technological knowledge and improvements
x
21 The graduates will be able to control the physical, chemical, biological, toxicological and pharmaceutical characteristics of nanoformulations.
x
22 The graduates will have knowledge about the mechanism of actions of drugs, their side effects and the benefits of using controlled release and/or nanoformulations to increase the effects of drugs.
x
23 The graduates will become familiar with pharmaceutical data bases and knows how to use them to determine the state of the art of all pharmaceutical technologies.
x
contribution level: 1 (low) – 5 (high)
ECTS – workload table
Activity Number Time (hour) Total workload Class Hours 15 3 45
Other Applications
Final Examinations (including preparatory year) 1 2 2
Quiz
Term Paper/ Project
Portfolio Study
Reports
Learning Diary
Thesis/ Project
Seminar
Other
Working Hours out of Class 15 3 45
Assignments
Presentation
Mid-term Examinations (including time for preparation)
1 10 10
Project 15 2 30
Clinical Practice
Laboratory
Field Work
Total Workload 132
Total Workload / 25 5.28
ECTS Credit of Course 5